予防医療のすべて

出版社： 中山書店
著者：
発行日： 2018-07-05
分野： 臨床医学：一般  >  プライマリケア
ISBN： 9784521739083
電子書籍版： 2018-07-05 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

10,450 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

10,450 円(税込)

購入する

商品紹介

現在わが国の平均寿命と健康寿命の間には男女ともに10年以上の乖離があり，これからの医療費の高騰が問題視されている．
本書では健康寿命を延ばすための「予防医療」に焦点をあて，プライマリ・ケアの介入によって疾患の重症化や不必要な入院を減らしてヘルスリテラシーを高めるため，総合診療医として知っておくべき情報や，検診/健診・予防接種の実態などが詳細に記載されている．

目次

  • 1章　予防医療と健康維持
    　予防医療とは
    　予防医療
    　スクリーニング
    　予防接種
    　カウンセリング
    　その他の予防医療　
    　予防医療の費用対効果
    　COLUMN　健診/検診を受けるかどうか論理的に考えると

    2章　発生予防
    　小児の虐待・事故の予防
    　望まない妊娠・異常妊娠の予防
    　更年期症状・骨盤臓器脱の予防
    　サプリメント，栄養補助食品などの摂取
    　運動による予防 ベネフィットとリスク
    　スポーツ障害の予防
    　糖尿病・メタボリックシンドロームの予防　生活習慣改善支援
    　Special Lecture アスピリンの予防的内服
    　COLUMN　忘れられた万能の予防薬？ Polypill
    　プレホスピタルケア　医療のフォーカスを院外へ
    　アドバンス・ケア・プランニング（ACP） 急性期医療との連携
    　高齢者総合機能評価（CGA） 高齢者は「歳をとった大人」ではない
    　認知症の発生予防
    　廃用症候群・サルコペニアの予防
    　褥瘡の予防
    　高齢者の骨粗鬆症・転倒の予防
    　施設での転倒・せん妄の予防
    　介護予防
    　高齢者虐待の予防
    　がんと診断された時からの緩和ケア　早期緩和ケアの導入によって何が予防されるのか
    　正常な死別の悲しみに寄り添う面接
    　不眠予防
    　自殺予防
    　労働者の疲労と睡眠　過労リスクとオンとオフのメリハリの重要性
    　交通事故予防 運転者として 歩行者として
    　周術期合併症予防
    　感染症の曝露後予防
    　地域での耐性菌発生予防
    　Choosing Wiselyキャンペーン　過剰医療がもたらす健康リスクを問う

    3章　救急受診・重症化予防－ACSCの考え方
    　ACSCとは
    　ACSC関連因子
    　Acute ACSC
    　Chronic ACSC
    　Vaccine preventable ACSC
    　低出生体重児
    　熱性けいれん
    　不定愁訴

    4章　予防医療の実践
    　予防を診療の中に組み込む
    　Health Promotion－地域へ出よう
    　予防医療のジレンマ
    　COLUMN　価値に基づく診療（value-based practice：VBP）と予防

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 予防医療と健康維持

P.4 掲載の参考文献
1) Winslow CE. The untilled fields of public health. Science 1920 ; 51 (1306) : 23-33.
PubMed
2) Fletcher RH, et al. Clinical Epidemiology : the Essentials, 5th ed. Lippincott Williams & Wilkins ; 2014. pp152-154.
 
3) Rose G (著) /曽田研二, 田中平三 (監訳), 水嶋春朔ほか (訳). 予防医学のストラテジー-生活習慣病対策と健康増進. 医学書院 ; 1998.
 
P.7 掲載の参考文献
1) USPSTF. Published Recommendations. https://www.uspreventiveservicestaskforce.org/BrowseRec/Index
 
2) Lynn S Bickley. Bates'Guide to Physical Examination and History Taking, 11th ed. LWW ; Eleventh, North American edition, 2012. p6.
 
3) AHRQ ePSS EIectronic Preventive Services Selector. https://epss.ahrq.gov/PDA/index.jsp
 
4) 国立がん研究センター社会と健康研究センター検診研究部検診評価研究室. 科学的根拠に基づくがん検診推進のページ http://canscreen.ncc.go.jp/
 
5) 笠井祥子, 南郷栄秀. <特集 患者にきちんと届く! 届ける! 予防医療プラクティス> 予防医療の推奨がどのようにしてつくられるのか? -USPSTFと科学的根拠に基づくがん検診を例に. Gノート 2017 ; 4 (3) : 549-556,
Medical*Online
岡田唯男. 一目で分かる予防医学 : health maintenance→スクリーニング (検診/健診) を中心に (One Pager). 2014/8. https://jascribd.com/document/338731043 (最終アクセス 2018/5/2)
 
P.14 掲載の参考文献
1) UK National Screening Committee. Public Health England. Screening and quality assurance (all programmes). 2013, Feb. 1.
PubMed
2) U. S. Preventive Services Task Force. April. Draft Recommendation Statement : Screening for Prostate Cancer. Is Prostate Cancer Screening Right for You? Understanding the Potential Benefits vs. Risks for Men 55 and Older. www.screeningforprostatecancer.org (2018年5月現在 "Prostate Cancer Screening Final Recommendation" に更新)
 
3) Jorgensen KJ, et al. Breast Cancer Screening in Denmark : A Cohort Study of Tumor Size and Overdiagnosis. Ann Intern Med 2017 ; 166 (5) : 313-323.
 
4) 科学的根拠に基づくがん検診 推進のページ [HP]. がん検診ガイドラインの考え方 http://canscreen.ncc.go.jp/kangae/kangae7.html
 
5) Sackett DL. The arrogance of preventive medicine. CMAJ 2002 ; 167 : 363-364.
PubMed
6) Krogsboll LT, et al. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012 ; 10 : CD009009.
 
7) U. S. Preventive Services Task Force. Guide to Clinical Preventive Services : Report of the U. S. Preventive Services Task Force. 2nd ed. Williams & Wilkins ; 1996.
 
Raffle AE, Gray JAM (著) /福井次矢ほか (監訳). スクリーニング-健診, その発端から展望まで. 同人社 ; 2009.
 
P.18 掲載の参考文献
1) Wilson JMG, Jungner G. The principles and practice of screening for disease. Public Health Papers no. 34. World Health Organization ; 1968. http://apps.who.int/iris/bitstream/handle/10665/37650/WHO_PHP_34.pdf?sequence=17
 
2) Frame P, Carlson S. A Critical Review of Periodic Health Screening Using Specific Screening Criteria. Part 2 : Selected Endocrine, Metabolic and Gastrointestinal Diseases. J Fam Pract 1975 ; 2 (2) : 123-129.
 
3) 科学的根拠に基づくがん検診推進のページ [HP]. がん検診 Q&A 医療従事者向け. http://canscreen.ncc.go.jp/qanda/iryou.html
 
4) 科学的根拠に基づくがん検診推進のページ [HP]. がん検診ガイドラインの考え方-なぜ「発見率」ではだめなのか. http://canscreen.ncc.go.jp/kangae/kangae2.html
 
5) 科学的根拠に基づくがん検診推進のページ [HP]. がん検診ガイドラインの考え方-なぜ「生存率」ではだめなのか. http://canscreen.ncc.go.jp/kangae/kangae3.html
 
6) 宮内昭. 甲状腺検診. 臨牀と研究 1997 ; 74 (7) : 1745-1748.
Medical*Online
7) 武部晃司ほか. 超音波検査を用いた甲状腺癌検診の実際とその問題点. KARKINOS 1994 ; 7 (4) : 309-317.
 
8) McWhinney IR, Freeman T. Textbook of Family Medicine. 3rd ed. Oxford University Press ; 2009.
 
Raffle AE, Gray JAM (著) /福井次矢ほか (監訳). スクリーニング-健診, その発端から展望まで. 同人社 ; 2009.
 
P.21 掲載の参考文献
乳幼児健康診査の実施と評価ならびに多職種連携による母子保健指導のあり方に関する研究班. 標準的な乳幼児期の健康診査と保健指導に関する手引き-「健やか親子 21 (第2次)」の達成に向けて, 2015. http://sukoyaka21.jp/pdf/H27manyual_yamazaki.pdf
 
福岡地区小児科医会 乳幼児保健委員会 (編). 乳幼児健診マニュアル 第5版. 医学書院 ; 2015.
 
文部科学省スポーツ・青少年局学校健康教育課 (監修). 児童生徒等の健康診断マニュアル 平成27年度改訂. 日本学校保健会 ; 2015. http://www.gakkohoken.jp/books/archives/187
 
P.25 掲載の参考文献
1) Kuh D, Ben-Shlomo Y. A Life Course Approach to Chronic Disease Epidemiology : Tracing the Origins of Ill-Health from Early to Adult Life. Oxford University Press ; 1997.
 
2) 日本産科婦人科学会, 日本産婦人科医会 (編). 産婦人科診療ガイドライン産科編 2017. 日本産科婦人科学会 : 2017. http://www.jsog.or.jp/activity/pdf/gl_sanka_2017.pdf
 
3) National Institute for Health and Care Excellerlce (NICE) [HP]. Antenatal and postnatal mental health : clinical management and service guidance Clinical guideline [CG192] published date : December 2014, last updated : April 2018. https://www.nice.org.uk/guidance/cg192
 
4) 日本産婦人科医会 (編). 妊産婦メンタルヘルスケアマニュアル-産後ケアへの切れ目ない支援に向けて. 日本産婦人科医会 ; 2017.
 
P.29 掲載の参考文献
1) Yourman LC, et al. Prognostic indices for older adults : a systematic review. JAMA 2012 ; 307 (2) : 182-192.
PubMed
2) Celli BR, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004 ; 350 (10) : 1005-1012.
PubMed
3) Holmes HM, et al. Rationalizing prescribing for older patients with multimorbidity : considering time to benefit. Drugs Aging 2013 ; 30 (9) : 655-666.
PubMed
4) Vollrath AM, et al. Discontinuing cardiovascular medications at the end of life : lipid-lowering agents. J Palliat Med 2005 ; 8 (4) : 876-881.
PubMed
5) Lee SJ, et al. Time lag to benefit after screening for breast and colorectal cancer : meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ 2013 ; 346 : e8441.
PubMed
6) Medina-Walpole A, et al (eds). Geriatrics Review Syllabus. 9th ed. American Geriatrics Society ; 2016. pp85-100.
 
7) Haynes RB, et al. Physicians' and patients' choices in evidence based practice. BMJ 2002 ; 324 (7350) : 1350.
PubMed
8) Stone MJ. Goals of care at the end of life. Proc (Bayl Univ Med Cent) 2001 ; 14 (2) : 134-137.
PubMed
P.34 掲載の参考文献
1) Bibbins-Domingo K, et al. Screening for colorectal cancer : US Preventive Services Task Force recommendation statement. JAMA 2016 ; 315 : 2564-2575.
PubMed
2) 日本消化器病学会 (編). 大腸ポリープ診療ガイドライン 2014. 南江堂 ; 2014, pp8-25.
 
3) 平成16年度厚生労働省癌研究助成金「がん検診の適切な方法とその評価法の確立に関する研究」班. 有効性評価に基づく大腸がん検診ガイドライン. 2005. http://canscreen.ncc.go.jp/pdf/guideline/colon_full080319.pdf (最終アクセス 2017-10-01)
 
4) Levin B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008 : a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008 ; 58 : 130-160.
PubMed
5) Rex DK, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009 ; 104 : 739-750.
PubMed
6) 厚生労働省 [HP]. 国民生活基礎調査 (平成28年). www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa16/index.html (最終アクセス 2017-10-01)
 
7) Peirson L, et al. Screening for cervical cancer : a systematic review and meta-analysis. Syst Rev 2013 ; 2 : 35.
PubMed
8) 平成20年度 厚生労働省がん研究助成金「がん検診の適切な方法とその評価法の確立に関する研究」班, 平成21年度 厚生労働省がん研究助成金「がん検診の評価と在り方に関する研究」班. 有効性評価に基づく子宮頸がん検診ガイドライン. 2009.
 
9) 日本産科婦人科学会/日本産婦人科医会 (編), 産婦人科診療ガイドライン-婦人科外来編 2017. 日本産科婦人科学会事務局 ; 2017.
 
10) Moyer VA. Screening for cervical cancer : U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012 ; 156 : 880-891.
PubMed
11) Saslow D, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012 ; 62 : 147-172.
PubMed
12) Independent UK panel on breast cancer screening. The benefits and harms of breast cancer screening : an independent review. Lancet 2012 ; 380 : 1778-1786.
PubMed
13) Siu AL. Screening for breast cancer : U. S. preventive services task force recommendation Statement. Screening for breast cancer. Ann Intern Med 2016 ; 164 : 279-296.
PubMed
14) 日本乳癌学会 (編), 科学的根拠に基づく乳癌診療ガイドライン 2 疫学・診断編 (2015年版). 金原出版 ; 2015.
 
15) 「科学的根拠に基づくがん検診法の有効性評価とがん対策計画立案に関する研究」班. 有効性評価に基づく乳がん検診ガイドライン (2013年度版), 2014.
 
16) Oeffeinger KC, et al. Breast cancer screening for women at average risk : 2015 guideline update from the American Cancer Society. JAMA 2015 ; 314 : 1599-1614.
 
17) 平成18年度厚生労働省がん研究助成金「がん検診の適切な方法とその評価法の確立に関する研究」班. 有効性評価に基づく肺がん検診ガイドライン, 2006. http://canscreen.ncc.go.jp/pdf/guideline/guide_lung070111.pdf
 
18) Sagawa M, et al. The efficacy of lung cancer screening conducted in 1990s : four case-control studies in Japan. Lung Cancer 2003 ; 41 : 29-36.
PubMed
19) Manser R, et al. Screening for lung cancer. Cochrane Database Syst Rev 2013 : (6) : CD001991. doi : 10.1002/14651858.CD001991.pub3.
 
20) National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011 ; 365 : 395-409.
 
21) Wender R, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Ciin 2013 ; 63 : 107-117.
 
22) Bach PB, et al. Benefits and harms of CT screening for lung cancer : a systematic review. JAMA 2012 ; 307 : 2418-2429.
PubMed
23) 日本CT検診学会ガイドライン委員会. 日本における低線量CTによる肺がん検診の考え方, 2013. www.jscts.org/pdf/guideline/ct130726.pdf (最終アクセス 2017-10-01)
 
24) Moyer VA. Screening for lung cancer : U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014 ; 160 : 330-338.
PubMed
25) American Academy of Family Physicians [HP]. Clinical Preventive Service Recommendation : Lung cancer. http://www.aafp.org/patient-care/clinical-recommendations/all/lung-cancer.html (最終アクセス 2017-10-01)
 
P.38 掲載の参考文献
1) Bellcross CA, et al. Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammograhy population. Genet Med 2009 ; 11 (11) : 783-789.
 
2) Ashton-Prolla P, et al Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care, BMC Cancer 2009 ; 9 : 283
PubMed
P.41 掲載の参考文献
1) 国立がん研究センターがん対策情報センター [HP]. がん情報サービス. がんの統計 '16 https://ganjoho.jp/reg_stat/statistics/brochure/backnumber/2016_jp.html
 
2) NCI [HP]. SEER Cancer Statistics Review 1975-2014 https://seer.cancer.gov/csr/1975_2014/
 
3) Britton JP, et al. A community study of bladder cancer screening by the detection of occult urinary bleeding. J Urol 1992 ; 148 (3) : 788-790.
PubMed
4) Mandelblatt J, et al. Collaborative Modeling of U. S. Breast Cancer Screening Strategies. AHRQ publication No. 14-05201-EF-4. Agency for Healthcare Research and Quality ; 2015.
 
5) Melnikow J, et al. Screening for Breast Cancer With Digital Breast Tomosynthesis. Evidence Synthesis No. 125, AHRQ Publication No. 14-05201-EF-2. Agency for Healthcare Research and Quality ; 2016.
 
6) Blot WJ, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988 ; 48 (11) : 3282-3287.
PubMed
7) Gupta PC, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980 ; 8 (6) : 283-333.
 
8) Sankaranarayanan R, et al. Effect of screening on oral cancer mortality in Kerala, India : a cluster-randomised controlled trial. Lancet 2005 ; 365 : 1927-1933.
PubMed
9) Stang A, Jockel KH. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany. Cancer 2016 ; 122 (3) : 432-437.
PubMed
P.45 掲載の参考文献
1) Karimi P, et al. Gastric cancer : descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 2014 ; 23 (5) : 700-713.
PubMed
2) Waddell T, et al. Gastric cancer : ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol 2014 ; 40 (5) : 584-591.
PubMed
3) Oshima A, et al. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 1986 ; 38 (6) : 829-833.
PubMed
4) Fukao A, et al. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan : a population-based case-control study. Int J Cancer 1995 ; 60 (1) : 45-48.
PubMed
5) 阿部陽介ほか. case-control studyの手法を用いた胃癌死亡減少に対する胃癌集団検診の効果の疫学的評価-胃集検の効率化の検討. 日本消化器病学会雑誌 1995 ; 92 : 836-845.
Medical*Online
6) 坪野吉孝, 久野茂. 症例対照研究による胃がん検診の死亡率減少効果の評価. 消化器集団検診 1999 ; 37 : 182-185.
 
7) Japan Collaborative Cohort Study Group, Mizoue T, et al. Prospective study of screening for stomach cancer in Japan. Int J Cancer 2003 ; 106 (1) : 103-107.
 
8) 乾純和ほか. 胃がん検診と日常診療のかかわり. 日本がん検診・診断学会誌 2014 ; 21 : 281-285,
Medical*Online
9) 厚生労働省. がん対策推進基本計画 (平成30年3月). http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000196975.pdf
 
10) Hamashima C, et al. A community-based, case-control study evaluating mortality reduction from gastric cancer by endoscopic screening in Japan. PLoS One 2013 ; 8 (11) : e79088.
PubMed
11) Matsumoto S, Yoshida Y. Efficacy of endoscopic screening in an isolated island : a case-control study. Indian J Gastroenterol 2014 ; 33 (1) : 46-49.
 
12) Yoshida T, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer 2014 ; 134 (6) : 1445-1457.
PubMed
13) 日本胃がん予知・診断・治療研究機構 (編). 胃がんリスク検診 (ABC検診) マニュアル 改訂2版. 南山堂 ; 2014.
 
国立がん研究センターがん予防・検診研究センター. 有効性評価に基づく胃がん検診ガイドライン 2014年版. http://canscreen.ncc.go.jp/pdf/iganguide150331.pdf
 
小嶋一ほか (編). [特集] 外来における予防医療. Hospitalist 2015 ; 3 (2) : 275-511,
 
P.50 掲載の参考文献
1) 日本耳鼻咽喉学会 [HP]. 重要なお知らせ「2015-2016年にかけて発症したムンプス難聴の大規模全国調査」2017. 9. 22 http://www.jibika.or.jp/members/jynews/info_mumps.pdf
 
2) 日本小児科学会 [HP]. 学会の考え方・提言・見解等「日本小児科学会の予防接種の同時接種に対する考え方」2014. 1. 12更新 https://www.jpeds.or.jp/uploads/files/saisin_1101182.pdf
 
3) 日本小児科学会 [HP]. 学会の考え方・提言・見解等「小児に対するワクチンの筋肉内接種法について (改訂版)」2016. 7. 8 http://www.jpeds.or.jp/uploads/files/20160708_kinnnikunaisesshu.pdf
 
日本小児科学会 HP [各種活動→予防接種・感染症] https://www.jpeds.or.jp/modules/activity/index.php?content_id=92
 
日本ワクチン産業協会「予防接種に関する Q&A集 2017」http://www.wakutin.or.jp/medical/index.html#book01
 
know VPD 1 VPDを知って子供を守ろう http://www.know-vpd.jp
 
FORTH (フォース) 厚生労働省検疫所 http://www.forth.go.jp/index.html
 
日本プライマリ・ケア連合学会 ワクチンプロジェクトチーム (仮)
 
病原微生物感染情報 <特集> 急性B型肝炎 2006年4月～2015年12月. IASR 2016 : 37 (8) ; 147-148. https://www.niid.go.jp/niid/ja/hepatitis-b-m/hepatitis-b-iasrtpc/6672-438t.html
 
佐賀県感染症情報センター HP. 佐賀県健康増進課「保育所におけるB型肝炎集団発生調査報告書について」htt://www.kansen.pref.saga.jp/kisya/kisya/hb/houkoku160805.htm
 
P.56 掲載の参考文献
1) WHO. Weekly epidemiological record 2015 ; 90 (No. 9) : 69-88. http://www.who.int/wer/2015/wer9009.pdf
 
2) 予防接種に関する Q&A集. 日本ワクチン産業協会 ; 2017. pp85-100.
 
3) 鳥巣浩幸. 小児急性散在性脳脊髄炎の臨床像. 脳と発達 2011 ; 43 (suppl) : 5112.
 
4) 厚生労働省 [HP]. 日本脳炎ワクチン接種に関する Q&A. http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou21/dl/nouen_qa.pdf
 
P.60 掲載の参考文献
1) 国立感染症研究所 病原微生物検出情報 IASR. 香川大学における百日咳集団感染事例. IASR 2008 ; 29 (3) : 68-69. https://idsc.niid.go.jp/iasr/29/337/dj3372.html
 
2) 国立感染症研究所 病原微生物検出情報 IASR. 高知大学医学部および附属病院における百日咳集団発生事例. IASR 2008 ; 29 (3) : 70-71. https://idsc.niid.go.jp/iasr/29/337/dj3373.html
 
3) 国立感染症研究所 病原微生物検出情報 IASR. 青森県の消防署における百日咳集団感染事例について. IASR 2008 ; 29 (3) : 71-73. https://idsc.niid.go.jp/iasr/29/337/dj3374.html
 
4) CDC. Letter to Providers : Tdap and Influenza Vaccination of Pregnant Women Oct 9, 2014. https://www.cdc.gov/flu/pdf/professionals/providers-letter-pregnant-2014.pdf
 
5) 国立感染症研究所 病原微生物検出情報 IASR. 百日咳 2017年1月現在. IASR 2017 ; 38 (2) : 23-24. https://www.niid.go.jp/niid/ja/pertussis-m/pertussis-iasrtpc/7075-444t.html
 
6) 柳澤如樹ほか. 成人におけるジフテリア・百日咳・破傷風 (DPT) 3種混合ワクチン0.2mL接種の百日咳抗体への効果. 感染症学雑誌 2009 ; 83 : 7-11.
 
7) 国立感染症研究所. 百日咳ワクチン ファクトシート (平成29年2月10日). http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000184910.pdf
 
P.65 掲載の参考文献
1) Mutsch M, et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005 ; 40 : 1282-1287.
PubMed
2) Grohskopf LA, et al. Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 influenza season. MMWR Recomm Rep 2017 ; 66 (2) : 1-20.
 
3) WHO. Recommended composition of influenza virus vaccines for use in the 2018-2019 northern hemisphere influenza season. http://www.who.int/influenza/vaccines/virus/recommendations/2018_19_north/en/ (最終アクセス 2018/4/28)
 
4) 厚生労働省健康局健康課予防接種室. 平成29年度インフルエンザワクチン株の選定経緯. ISAR 2017 ; 38 (11) : 225-226. https://www.niid.go.jp/niid/ja/flu-m/flu-iasrtpc/7660-453t.html
 
5) Grohskopf LA, et al. Prevention and control of seasonal influenza with vaccines. MMWR Recomm Rep 2016 ; 65 (5) : 1-54,
 
6) Osterholm MT, et al. Efficacy and effectiveness of influenza vaccines : a systematic review and meta-analysis. Larlcet Infect Dis 2012 ; 12 : 36-44.
PubMed
7) Nichol KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995 ; 333 : 889-893.
PubMed
8) Demicheli V, et al. Vaccines for preventing influenza in the elderly.. Cochrane Database Syst Rev 2018 ; 2 : CD004876.
PubMed
9) Jefferson T, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010 ; (2) : CD004876.
 
10) Centers for Disease Control and Prevention (CDC). Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep 2013 ; 62 (RR-07) : 1-43.
 
11) Grohskopf LA, et al. Prevention and control of influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 influenza season. MMWR Morb Mortal Wkly Rep 2015 ; 64 : 818-825.
 
12) Peasah SK, et al. Influenza cost and cost-effectiveness studies globally--a review. Vaccine 2013 ; 31 : 5339-5348.
PubMed
13) Paules CI, et al. Chasing seasonal influenza-the need for a universal influenza vaccine. N Engl J Med. 2018 ; 378 (1) : 7-9.
PubMed
P.68 掲載の参考文献
1) 厚生労働省 [HP]. 子宮頸がん予防ワクチン Q&A http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/qa_shikyukeigan_vaccine.html
 
2) Garland SM, et al. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine : A Systematic Review of 10 Years of Real-world Experience. Clin Infect Dis 2016 ; 63 (4) : 519-527.
PubMed
3) Arbyn M, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors, Cochrane Database Syst Rev 2018 ; 5 : CD009069.
PubMed
4) Ozawa N et al. Beneficial Effects of Human Papillomavirus Vaccine for Prevention of Cervical Abnormalities in Miyagi, Japan. Tohoku J Exp Med 2016 ; 240 (2) : 147-151.
PubMed
5) Tanaka H, et al. Preventive effect of human papillomavirus vaccination on the development of uterine cervical lesions in young Japanese women. J Obstet Gyrlaecol Res 2017 ; 43 (10) : 1597-1601.
PubMed
6) Matsumoto K, et al. Early impact of the Japanese immunization program implemented before the HPV vaccination crisis. Int J Cancer 2017 ; 141 : 1704-1706.
PubMed
7) Aratani S, et al. Retraction : Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration human papilloma virus vaccine and pertussis toxin. Sci Rep 2018 ; 8 : 46971.
PubMed
8) 第23回厚生科学審議会予防接種・ワクチン分科会副反応検討部会 資料 4. 「全国疫学調査 (子宮頸がんワクチンの有効性と安全性の評価に関する疫学研究)」2016年12月26日. http://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000147016.pdf
 
9) Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women : Results of the Nagoya study. Papillomavirus Res 2018 ; 5 : 96-103.
PubMed
P.72 掲載の参考文献
1) Demicheli V, et al. Vaccines for rneasles, mumps and rubella in children. Cochrane Database Syst Rev 2012 ; (2) : CD004407.
 
2) Lanzieri TM, et al. Impact of rubella vaccination strategy on the occurrence of congenltal rubella syndrome. J Pediatr (Rio J) 2007 ; 83 : 415-421.
PubMed
3) 岡部信彦, 多屋馨子. 予防接種に関するQ&A集 2016年版. 日本ワクチン産業協会 : 2016. pp9-45, pp95-124, pp212-217.
 
P.76 掲載の参考文献
1) 国立感染症研究所 HP. 「破傷風とは」https://www.niid.go.jp/niid/ja/kansennohanashi/466-tetanis-info.html
 
P.79 掲載の参考文献
1) Sato K, et al. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older : Results from an observational, prospective, physician practice-based cohort study. J Dermatol 2017 ; 44 (4) : 414-422.
PubMed
P.83 掲載の参考文献
1) Remschmidt C, et al. Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly : a systematic review. BMC Infect Dis 2016 ; 16 (1) : 711.
PubMed
2) 日本呼吸器学会/日本感染症学会合同委員会, 「65歳以上の成人に対する肺炎球菌ワクチン接種に関する考え方 (第2版 2017-10-23)」http://www.kansensho.or.jp/guidelines/pdf/065haienV/065haienV_171023.pdf
 
3) 日本感染症学会. 肺炎球菌ワクチン再接種のガイダンス [改訂版] (2017年7月20日) http://www.kansensho.or.jp/guidelines/pdf/pneumococcus_vaccine_re_1707.pdf
 
4) CDC. Pneumococcal vaccine Timing for Adults https://www.cdc.gov/vaccines/vpd/pneumo/downloads/pneumo-vaccine-timing.pdf
 
P.88 掲載の参考文献
1) U. S. Department of Health, Education, and Welfare. Healthy People : the Surgeon Generars Report on Health Promotion and Disease Prevention. US Government Printing Office ; 1979.
 
2) Mokdad AH, et al. Actual causes of death in the United States, 2000. JAMA 2004 ; 291 (10) : 1238-1245.
PubMed
3) Prochaska JO, DiClemente CC. Transtheoretical therapy : Toward a more integrative model of change. Psychotherapy : Theory, Research & Practice 1982 ; 19 (3) : 276-288.
 
4) Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997 ; 12 (1) : 38-48.
PubMed
5) Janis IL, Mann L. Decision Making : A Psychological Analysis of Conflict, Choice and Commitment. Free Press ; 1977.
 
6) Bandura A, Self-efficacy : toward a unifying theory of behavior change. Psychol Rev 1977 ; 84 (2) : 191-215.
 
7) Prochaska JO, et al. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 1993 : 12 (5) : 399-405.
PubMed
8) Rossi SR, et al. A processes of change model for weight control for participants in community-based weight loss programs. Int J Addict 1994 ; 29 (2) : 161-77.
PubMed
9) Noar SM, et al. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol Bull 2007 : 133 (4) : 673-693.
PubMed
10) Keller VF, White MK. Choices and changes : a new model for influencing patient health behavior, J Clin Outcomes Manage 1997 ; 4 (6) : 33-36.
 
11) U. S. Department of Health and Human Services Public Health Service. Treating Tobacco Use and Dependence : 2008 Update. Clinical Practice Guideline. May, 2008.
 
12) 松本千明. 医療・保健スタッフのための健康行動理論の基礎-生活習慣病を中心に. 医歯薬出版 ; 2002.
 
13) Berlin EA, Fowkes WC. A teaching framework for cross-cultural health care. West J Med 1983 ; 139 (6) : 934-938.
PubMed
土井由利子. 日本における行動科学研究-理論から実践へ. 保健医療科学 2009 ; 58 (1) : 2-10.
 
Patricia M, et al (eds). Promoting Exercise and Behavior Change in Older Adults : Interventions With the Transtheoretical Model. Springer Publish Company ; 2002/竹中晃二 (監訳). 高齢者の運動と行動変容-トランスセオレティカル・モデルを用いた介入. Book House HD ; 2005.
 
Y大学 体育・スポーツ心理学研究室 [HP]. 「トランスセオレティカル・モデル」http://blogs.yahoo.co.jp/uechihiroaki/13312460.html
 
津田彰ほか. 多理論統合モデル (TTM) にもとづくストレスマネジメント行動変容ステージ別実践ガイド. 久留米大学心理学研究 2010 ; No 9 : 77-88.
 
中村正和. 行動変容のステージモデルに基づいた禁煙サポート. 治療 2000 ; 82 (2) : 335-342, 135-141.
 
松下明, 週刊医学界新聞 [連載] 研修医イマイチ先生の成長日誌-行動科学で学ぶメディカルインタビュー (全10回). 2874号 (2010) ～2911号 (2011). http://www.igaku-shoin.co.jp/paperDetaiLdo?id=PA02874_07
 
厚生労働省 e-ヘルスネット [情報提供] https://www.e-healthnet.mhlw.go.jp/information/exercise-summaries/s-07
 
岡田唯男. 無関心期≠前熟考期?? : ProchaskaのTTM (transtheoretical model : トランスセオレティカルモデル/行動変容のステージ) に関する6つの誤解 https://pcij.wordpress.com/2014/07/28/ttm/
 
U. S. Department of Health and Human Services, et al. Theory at a Glance : A Guide For Health Promotion Practice, 2nd ed NIH Publication ; 2005/福田吉治ほか (監修). 一目で分かるヘルスプロモーション-理論と実践ガイドブック. 国立保険医療科学院 ; 2008.
 
P.93 掲載の参考文献
1) 日本禁煙学会 (編). 禁煙学 Tobacco Control Advocacy, 第3版. 南山堂 ; 2014.
 
2) 一般社団法人日本禁煙学会 [HP] http://www.jstc.or.jp/
 
3) 厚生労働省. 禁煙支援マニュアル (第二版) /禁煙とたばこ依存症治療のための政策提言 http://www.mhlw.go.jp/topics/tobacco/kin-en-sien/
 
4) 日本循環器学会, 日本肺癌学会, 日本癌学会, 日本呼吸器学会. 禁煙治療のための標準手順書, 第6版. 2014年4月. http://www.j-circ.or.jp/kinen/anti_smoke_std/pdf/anti_smoke_std_rev6.pdf
 
5) Mokdad AH, et al. Actual Causes of Death in the United States, 2000. JAMA 2004 ; 291 (10) : 1238-1245.
PubMed
6) Ikeda N, et al. Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan : a comparative risk assessment. PLoS Med 2012 ; 9 (1) : e1001160.
PubMed
7) U. S. Preventive Services Task Force. Final Update Summary : Tobacco Smoking Cessation in Adults. Including Pregnant Women : Behavioral and Pharmacotherapy Interventions. September 2015. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions1
 
8) 日本禁煙学会. PM2.5問題に関する日本禁煙学会の見解と提言. 2013年2月9日 http://www.nosmoke55.jp/action/1302pm25.html
 
9) 中村正和 (研究代表者). 厚生労働科学研究費補助金 (第3次対がん総合戦略研究事業) 総括・分担研究報告書「発がんリスクの低減に資する効果的な禁煙推進のための環境整備と支援方策の開発ならびに普及のための制度化に関する研究」平成22年度, 2011.
 
10) 中村正和 (研究代表者). 厚生労働科学研究費補助金 (第3次対がん総合戦略研究事業) 総括・分担研究報告書「発がんリスクの低減に資する効果的な禁煙推進のための環境整備と支援方策の開発ならびに普及のための制度化に関する研究」平成23年度, 2012.
 
11) Fiore MC, et al. Clinical Practice Guideline-Treating Tobacco Use and Dependence : 2008 Update. U. S. Department of Health and Human Services : 2008.
 
12) 中山富雄, 嶋田ちさ. 健診・検診や保健指導の場における禁煙支援の事例報告 (1) 地域の事例報告. 大井田隆ほか (編). 特定健康診査・特定保健指導における禁煙支援から始めるたばこ対策. 日本公衆衛生協会 ; 2013. pp125-133.
 
13) Anthony JC, et al. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants : Basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994 ; 2 (3) : 244-268.
 
14) Royal College of Physicians of London. Tobacco Advisory Group. Nicotine Addiction in Britain : A Report of the Tobacco Advisory Group of the Royal College of Physicians. Royal College of Physicians ; 2000.
 
15) Hunt WA, et al. Relapse rates in addiction programs. J Clin Psychol 1971 ; 27 (4) : 455-456.
PubMed
16) Lachenmeier DW, Rehm J. Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Sci Rep 2015 ; 5 : 8126.
PubMed
17) McNeill A, et al. Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England. Public Health England ; 2018.
 
18) NHS. Stop smoking treatments. NHS Health A-Z. https://www.nhs.uk/conditions/stop-smoking-treatments/ (2016/7/19)
 
P.97 掲載の参考文献
1) Osaki Y, et al. Prevalence and Trends in Alcohol Dependence and Alcohol Use Disorders in Japanese Adults ; Results from Periodical Nationwide Surveys. Alcohol Alcohol 2016 ; 51 (4) : 465-473.
PubMed
2) 大脇由紀子, 吉本尚. 「アルコール健康障害対策基本法」の施行と看護師に必要な専門知識-アルコールに関連する身体疾患を中心に. 日本看護医療学会雑誌 2016 ; 18 (2) : 22-30.
Medical*Online
3) 廣尚典, 島悟. 問題飲酒指標AUDIT日本語版の有用性に関する検討. 日本アルコール・薬物医学会雑誌 1996 ; 31 (5) : 437-450.
 
4) Osaki Y, et al. Reliability and validity of the alcohol use disorders identification test-consumption in screening for adults with alcohol use disorders and risky drinking in Japan. Asian Pac J Cancer Prev 2014 ; 15 (16) : 6571-6574.
PubMed
5) 廣尚典 : CAGE, AUDITによる問題飲酒の早期発見-アルコール関連障害とアルコール依存症. 日本臨床 1997 ; 55 (特別号) : 589-593.
 
P.99 掲載の参考文献
1) 吉本尚. プライマリ・ケア医ならできるアルコール問題への予防介入. 松本俊彦, 宮崎仁 (編), いまどきの依存とアディクション-プライマリ・ケア/救急における関わりかた入門. 南山堂 ; 2015. pp198-203.
 
2) WHQ The ICD-10 Classification of Mental and Behavioral Disorders : Clinical Descriptions and Diagnostic Guidelines. World Health Organization ; 1992/融道男ほか (監訳). ICD-10 精神および行動の障害-臨床記述と診断ガイドライン 新訂版. 医学書院 ; 2005.
 
3) Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005 ; 352 (6) : 596-607.
PubMed
P.102 掲載の参考文献
1) U. S. Preventive Services Task Force. USPSTF A and B Recommendations by Date. (最終アクセス 2018/4/30) https://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b-recommendations-by-date/
 
2) Adult screening and prevention recommendations of USPSTF D recommendations (discourage use of this service). Up to Date https://www.uptodate.com/contents/image?imageKey=PC%2F58200
 
3) U. S. Preventive Services Task Force. Grade Definitions. (最終アクセス 2018/4/30) https://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions
 
4) 小嶋一ほか (編集). <特集> 外来における予防医療. Hospitalist (ホスピタリスト) 2015 ; 3 (2) : 275-511.
 
5) 岡田唯男. 診療のプロが考える経済的負担を減らすための選択肢-脂質異常症. 薬局 2018 ; 69 (5) : 42-48.
 
6) 南郷栄秀 (編集). 動脈硬化御三家-高血圧・糖尿病・脂質異常症をまるっと制覇! Gノート増刊 (Vol 5-No 2) 羊土社 ; 2018.
 
P.107 掲載の参考文献
1) Drummond MF, et al. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press ; 2015.
 
2) Pandya A, et al. Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease. JAMA 2015 ; 314 (2) : 142-150.
PubMed
3) Onishi Y, et al. Economic evaluation of pravastatin for primary prevention of coronary artery disease based on risk prediction from JALS-ECC in Japan. Value Health Reg Issues 2013 ; 2 (1) : 5-12.
PubMed
4) Cohen JT, et al. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 2008 ; 358 (7) : 661-663.
PubMed
五十嵐中, 佐條麻里. 「薬剤経済」わかりません!!. 東京図書 ; 2014.
 

2章 発生予防

P.112 掲載の参考文献
1) 厚生労働省. 子ども虐待対応の手引き (平成25年8月改正版). http://www.mhlw.go.jp/seisakunitsuite/bunya/kodomo/kodomo_kosodate/dv/dl/120502_11.pdf (最終アクセス 2018/4/1)
 
2) Pierce MC, et al. Bruising characteristics discriminating physical child abuse from accidental trauma. Pediatrics 2010 ; 125 (1) : 67-74.
PubMed
3) 厚生労働省. 要支援児童等 (特定妊婦を含む) の情報提供に係る保健・医療・福祉・教育等の連携の一層の推進について (平成28年12月16日/平成29年3月31日改正) http://www.mhlw.go.jp/file/06-Seisakujouhou-11900000-Koyoukintoujidoukateikyoku/1_19pdf (最終アクセス 2017/10/1)
 
4) 山中龍宏. 子どもの誤飲・事故 (やけど・転落など) を防ぐ本. 三省堂 ; 1999.
 
東京都生活文化局消費生活部生活安全課/Safe Kids Japan. Safe Kids-子供を事故から守るために. https://www.shouhiseikatu.metro.tokyo.jp/manabitai/kyouzai/main/documents/323.pdf
 
P.117 掲載の参考文献
1) Practice Bulletin No. 152 : Emergency contraception, Obstet Gynecol 2015 ; 126 (3) : e1-11.
PubMed
2) Bosworth MC, et al. An update on emergency contraception. Am Fam Physician 2014 ; 89 (7) : 545-550.
PubMed
3) Summary Chart of U. S. Medical Eligibility Criteria for Contraceptive Use. https://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eUgibility-criteria_508tagged.pdf (最終アクセス 2018/5/22)
 
4) Henderson JT, et al. Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia : A Systematic Evidence Review for the U. S. Preventive Services Task Force. Evidence Synthesis No 112. AHRQ Publication No. 14-05207-EF-1. Agency for Healthcare Research and Quality ; 2014.
 
日本産科婦人科学会 (編/監修). OC・LEPガイドライン 2015年度版. 日本産科婦人科学会 ; 2015.
 
日本産科婦人科学会/日本産婦人科医会 (編/監修), 産婦人科診療ガイドライン-婦人科外来編 2017. 日本産科婦人科学会 ; 2017.
 
井上真智子 (編) /柴田綾子, 水谷佳敬 (著). 女性の救急外来 ただいま診断中!. 中外医学社 ; 2017.
 
日本産科婦人科学会 (監修). HUMAN+女と男のディクショナリー http://humanplus.jp
 
FDA Drug Safety Communication : Updated information about the risk of blood clots in women taking birth control pills containing drospirenone. https://www.fda.gov/Drugs/DrugSafety/ucm299305.htm (最終アクセス 2018/5/22)
 
P.120 掲載の参考文献
1) 女性労働協会. 働く女性の健康に関する実態調査結果 (平成16年3月). http://www.jaaww.or.jp/about/pdf/document_pdf/health_research.pdf
 
2) 日本産科婦人科学会/日本産婦人科医会 (編/監修). 産婦人科診療ガイドライン-婦人科外来編 2017. 日本産科婦人科学会 ; 2017.
 
3) Stuenkel CA, et al. Treatment of symptoms of the menopause : an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2015 ; 100 (11) : 3975-4011.
PubMed
4) The American Congress of Obstetricians and Gynecologists (ACOG) Practice Bulletin No 141 : Management of Menopausal Symptoms. January 2014 (reaffirmed 2016).
 
5) U. S, Preventive Services Task Force. Recommendation Summary : Hormone Therapy in Postmenopausal Women : Primary Prevention of Chronic Conditions. December 2017. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/menopausal-hormone-therapy-preventive-medication1
 
6) The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 2017 ; 24 (7) : 728-753.
 
7) 日本産科婦人科学会/日本女性医学会 (編・監修). ホルモン補充療法ガイドライン 2017年度版. 日本産科婦人科学会 ; 2017.
 
8) The American Congress of Obstetricians and Gynecoiogists (ACOG) Practice Bulletin No 176 : Pelvic Organ Prolapse. April 2017.
 
P.123 掲載の参考文献
USPSTF [HP]. https://www.uspreventiveservicestaskforce.org/
 
消費者庁 [HP]. 健康や栄養に関する表示の制度について http://www.caa.go.jp/policies/policy/food_labeling/health_promotion/
 
日本健康・栄養食品協会 [HP]. http.//www.jhnfa.org/index.html
 
JIHFS日本健康食品規格協会 [HP]. http://www.jihfs.jp/
 
国立健康・栄養研究所. 「健康食品」の安全性・有効性情報. https://hfnet.nih.go.jp/
 
日本健康食品・サプリメント情報センター (編). 健康食品・サプリメント [成分] のすべて 2017-ナチュラルメディシン・データベース. 同文書院. 2017.
 
P.126 掲載の参考文献
1) Peterson DM. The benefits and risks of exercise. In : UpToDate, Post TW (Ed), UpToDate, Waltham MA (Accessed on February 25, 2018) https://www.uptodate. com/conents/the-benefits-and-risks-of-exercise
 
2) Vehrs PR. Physical activity and strength training in children and adolescents : An overview, In : UpToDate, Post TW (Ed), UpToDate, Waltham MA. (Accessed on February 25, 2018) https://www.uptodate.com/contents/physical-activity-and-strength-training-in-children-and-adolescents-an-overview
 
3) Morey MC. Physical activity and exercise in older adults. In : UpToDate, Post TW (Ed), UpToDate, Waltham MA. (Accessed on February 25, 2018) https://www.uptodate.com/contents/physical-activity-and-exercise-in-older-adults
 
4) Artal R. Exercise during pregnancy and postpartum period. In : UpToDate, Post TW (Ed), UpToDate, Waltham MA. (Accessed on February 25, 2018) https://www.uptodate.com/contents/exercise-during-pregnancy-and-the-postpartum-period
 
5) 国立健康・栄養研究所 (翻訳). 健康のための身体活動に関する国際勧告 (WHO) 日本語版. http://www.nibiohn.go.jp/files/kenzo20120306.pdf
 
P.129 掲載の参考文献
1) McCrory P, et al. Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin. October 2016. Br J Sports Med 2017 ; 51 : 838-847.
PubMed
2) Patricios JS, et al. Implementation of the 2017 Berlin Concussion in Sport Group Consensus Statement in contact and collision sports : a joint position statement from l l national and international sports organisations. Br J Sports Med 2018 ; 52 (10) : 635-641.
 
3) 日本臨床スポーツ医学会学術委員会脳神経外科部会. 頭部外傷10か条の提言 (第2版). 2015 https://concussionjapan.jimdo.com
 
4) 大内洋 (監修) /服部惣一, 山田慎 (編著). jmedmook 50 <あなたも名医!> 知っておこうよ, スポーツ医学-亀田スポーツ方式を日常診療に取り入れてみよう!. 日本医事新報社 ; 2017. pp. 187-189.
 
5) Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2017 Oct 30. pii : CIR, 0000000000000549.
 
6) Mirabelli MH, et al. The Preparticipation Sports Evaluation. Am Fam Physician 2015 ; 92 (5) : 371-376.
PubMed
7) Bergeron MF, et al. International Olympic Committee consensus statement on youth athletic development. Br J Sports Med 2015 ; 49 : 843-851.
PubMed
環境省. 熱中症予防情報サイト http://www.wbgt.env.go.jp/heatillness_gline.php
 
P.132 掲載の参考文献
1) Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 ; 346 : 393-403.
 
2) Tuomilehto J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 ; 344 : 1343-1350.
PubMed
3) Sakane N, et al. Effect of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes : J-DOIT1, a pragmatic cluster randomized trial. BMJ Open 2015 ; 5 : e007316.
 
4) 日本糖尿病学会 (編著). 糖尿病診療ガイドライン 2016. 南江堂 ; 2016. (学会HP http://www.jds.or.jp/modules/publication/index.php?content_id=4)
 
5) 松下明. プライマリ・ケアからみた糖尿病診療 (行動変容アプローチ). 糖尿病 2017 ; 60 : 346-349.
 
6) 日本動脈硬化学会 (編). 動脈硬化性疾患予防ガイドライン 2017年版. 日本動脈硬化学会 ; 2017.
 
P.136 掲載の参考文献
1) 日本心臓財団 [HP]. 川田志明. 柳から生まれたアスピリン. http://www.jhf.or.jp/bunko/mimiyori/08.html
 
2) U. S. Preventive Services Task Force. Aspirin prophylaxis in pregnancy. In : Guide to Clinical Preventive Services. 2nd ed. U. S. Department of Health and Human Services ; 1996.
 
3) Hayden M, et al. Aspirin for the Primary Prevention of Cardiovascular Events : A Summary of the Evidence for the U. S. Preventive Services Task Force. Ann Intern Med 2002 ; 136 (2) : 161-172.
 
4) Morimoto T, et al. Application of U. S. guidelines in other countries : aspirin for the primary prevention of cardiovascular events in Japan. Am J Med 2004 ; 117 (7) : 459-468.
PubMed
5) Final Recommendation Statement : Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer : Preventive Medication. U. S. Preventive Services Task Force. September 2017. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer?rf=48883
 
6) Ikeda Y, et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors. a randomized clinical trial. JAMA 2014 ; 312 (23) : 2510-2520.
 
7) 日本動脈硬化学会 [HP] 冠動脈疾患発症予測・脂質管理目標値設定ツール Web版 (吹田スコア) http://wwwj-athero.org/publications/gl2017_app.html (最終アクセス 2018/5/1)
 
8) Ferlay J, et al. GLOBOCAN 2012 v1.1, Cancer lncidence and Mortality Worldwide : IARC CancerBase No. 11 [Internet]. Lyon, France : International Agency for Research on Cancer ; 2014. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx https://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/colorectal-cancer-statistics
 
9) Guirguis-Blake JM, et al. Aspirin for the Primary Prevention of Cardiovascular Events : A Systematic Evidence Review for the U. S. Preventive Services Task Force [Internet]. Rockville (MD) : Agency for Healthcare Research and Quality (US) ; 2015 Sep. (Evidence Syntheses, No. 131.) Appendix E Table 4, Timeline of Publications of Aspirin for CVD Prevention With a Focus on Sex-Specific Conclusions, Available from : https://www.ncbi.nlm.nih.gov/books/NBK321632/table/appe.t4/
 
10) Anderson G. Acetylsalicylic acid and the primary prevention of cardiovascular disease. In : Canadian Task Force on the Periodic Health Examination. Health Canada ; 1994 : pp680-690.
 
11) Hennekens CH, et al. Aspirin as a therapeutic agent in cardiovascular disease : a statement for healthcare professionals from the American Heart Association. Circulation 1997 ; 96 (8) : 2751-2753.
PubMed
12) Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies in coronary prevention. Eur Heart J 1998 ; 19 (10) : 1434-1503.
 
13) American Diabetes Association. Aspirin Therapy in Diabetes. Diabetes Care 2001 ; 24 (suppl 10) : S62-S63.
 
14) Ridker PM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005 ; 352 (13) : 1293-1304.
PubMed
15) Berger JS, et al. Aspirin for the primary prevention of cardiovascular events in women and men : a sex-specific meta-analysis of randomized controlled trials. JAMA 2006 ; 295 (3) : 306-313.
 
16) Belch J, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial : factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008 ; 337 : a1840.
PubMed
17) Ogawa H, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes : a randomized controlled trial. JAMA 2008 ; 300 (18) : 2134-2141.
PubMed
18) Wolff T, et al. Aspirin for the primary prevention of cardiovascular events : an update of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med 2009 ; 150 (6) : 405-410.
 
19) Antithrombotic Trialists' (ATT) Collaboration, et al. Aspirin in the primary arld secondary prevention of vascular disease : collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009 ; 373 (9678) : 1849-1860.
 
20) Calonge N, Lefevre M. USPSTF Response to the ATT Collaboration Meta-Analysis. U. S. Preventive Services Task Force ; 2009 http://www.uspreventiveservicestaskforce.org/tfcomments/tfaspattcom.htm December 2009 (現在閲覧不能)
 
21) Pignone M, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes : a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care 2010 ; 33 (6) : 1395-1402.
 
22) American Diabetes Association. Standards of Medical Care in Diabetes-2011. Diabetes Care January 2011 ; 34 (Suppl 1) : S11-61.
 
23) Berger JS, et al. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease : a meta-analysis of randomized trials. Am Heart J 2011 ; 162 (1) : 115-124.
PubMed
24) Goldstein LB, et al. Guidelines for the primary prevention of stroke : aguideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011 ; 42 (2) : 517-584.
 
25) Vandvik PO, et al. Primary and secondary prevention of cardiovascular disease : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence--Based Clinical Practice Guidelines. Chest 2012 ; 141 (2 Suppl) : e637S-e668S.
 
26) 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告). 虚血性心疾患の一次予防ガイドライン (2012年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2012_shimamoto_h.pdf
 
27) Farrell B, et al. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial : final results. J Neurol Neurosurg Psychiatry 1991 ; 54 (12) : 1044-1054.
PubMed
28) USPSTF. Archived : Aspirin/NSAIDs for Prevention of Colorectal Cancer : Preventive Medication. Original Release Date : March 2007 https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/aspirin-nsaidsfor-prevention-of-colorectal-cancer-preventive-medication
 
29) Flossmann E, et al. Effect of aspirin on long-term risk of colorectal cancer : consistent evidence from randomised and observational studies. Lancet 2007 ; 369 (9573) : 1603-1613.
PubMed
30) Rothwell PM, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality : 20-year follow-up of five randomised trials. Lancet 2010 ; 376 (9754) : 1741-1750.
PubMed
31) Ishikawa H, et al. The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients : arandomised trial. Gut 2014 ; 63 (11) : 1755-1759.
PubMed
32) UMIN-CTR 臨床試験登録情報. 大腸腫瘍患者へのアスピリンによる発がん予防大規模臨床試験 (J-CAPP Study II) https://upload.umin.ac.jp/cgi-openbin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000021671&language=J
 
33) Redman CW. Hypertension in pregnancy : the NICE guidelines. Heart 2011 ; 97 (23) : 1967-1969.
PubMed
34) American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. American College of Obstetricians and Gynecologists ; 2013.
 
35) Final Recommendation Statement : Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia : Preventive Medication. U. S. Preventive Services Task Force. December 2016. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
 
P.140 掲載の参考文献
1) Prados-Torres A, et al. J Clin Epidemiol 2014 ; 67 (3) : 254-266.
PubMed
2) Claxton AJ, et al. Clin Ther 2001 ; 23 (8) : 1296-1310.
PubMed
3) Pasina L, et al. Drugs Aging 2014 ; 31 (4) : 283-289.
PubMed
4) Bangalore S, et al. Am J Med 2007 ; 120 (8) : 713-719.
PubMed
5) Yusuf S, et al. Lancet 2011 ; 378 (9798) : 1231-1243.
PubMed
6) World Health Organization. Secondary prevention of non-communicable disease in low and middleincome countries through community-based and health service interventions. World Health Organization-Wellcome Trust meeting report 1-3 August 2001, Geneva. http://www.who.int/cardiovascular_diseases/media/en/615.pdf
 
7) Wald NJ, Law MR. BMJ 2003 ; 326 (7404) : 1419.
PubMed
8) Wald NJ, et al. Eur J Epidemiol 2016 ; 31 (4) : 415-426.
PubMed
9) Kuehn BM. JAMA 2006 ; 296 (4) : 377-380.
PubMed
10) Roy A, et al. Curr Cardiol Rep 2017 ; 19 (5) : 45.
 
11) Huffman MD, et al. Lancet 2017 ; 389 (10073) : 1055-1065.
PubMed
12) Bahiru E, et al. Cochrane Database Syst Rev 2017 ; 3 : CD009868.
PubMed
13) Virdee SK, et al. BMJ Open 2013 ; 3 (3). pii : e002498.
 
14) Fiuza-Luces C, et al. Physiology (Bethesda) 2013 ; 28 (5) : 330-358.
PubMed
15) Iheozor-Ejiofor Z, et al. Cochrane Database Syst Rev 2015 ; (6) : CD010856.
PubMed
16) Yang Q, et al. Circulation 2006 ; 113 (10) : 1335-1343.
PubMed
17) Das JK, et al. Syst Rev 2013 ; 2 : 67.
PubMed
P.144 掲載の参考文献
1) 総務省消防庁. 平成29年版 救急・救助の現況. http://www.fdma.go.jp/neuter/topics/fieldList9_3.html
 
2) Iwami T, et al. Continuous improvements in "chain of survival" increased survival after out-of-hospital cardiac arrests : a large-scale population-based study. Circulation 2009 ; 119 : 728-734.
PubMed
3) Iwami T, et al. Dissemination of chest compression-only cardiopulmonary resuscitation and survival after out-of-hospital cardiac arrest. Circulation 2015 ; 132 : 415-422.
PubMed
4) Iwami T, et al. Effectiveness of bystander-initiated cardiac-only resuscitation for patients with out-of-hospital cardiac arrest. Circulation 2007 ; 116 : 2900-2907,
PubMed
5) 日本蘇生協議会 (監修). JRC蘇生ガイドライン 2015. 医学書院 ; 2016. (オンライン版 http://www.japanresuscitationcouncil.org/jrc蘇生ガイドライン2015/)
 
6) Kitamura T, et al. Public-access defibrillation and out-of-hospital cardiac arrest in Japan. N Engl J Med 2016 ; 375 : 1649-1659.
PubMed
P.147 掲載の参考文献
1) Singer PA, et al. Bioethics for clinicians : 6. Advance care planning. CMAJ 1996 ; 155 : 1689-1692.
PubMed
2) Morrison RS, et al. The effect of a social work intervention to enhance advance care planning documentation in the nursing home. J Am Geriatr Soc 2005 ; 53 : 290-294.
PubMed
3) Coppola KM, et al. Accuracy of primary care and hospital-based physicians'predictions of elderly outpatients' treatment preferences with and without advance directives. Arch Intern Med 2001 ; 161 : 431-440.
PubMed
4) Saultz Jw, Lochner J. Interpersonal continuity of care and care outcomes : a critical review. Ann Fam Med 2005 ; 3 (2) : 159-166.
PubMed
5) Oregon POLST. Physician orders for life-sustaining treatment (POLST). http://oregonpolst.org
 
6) Tierney WM, et al. The effect of discussions about advance directives on patients' satisfaction with primary care. J Gen Intern Med 2001 ; 16 : 32-40.
PubMed
P.153 掲載の参考文献
1) Barton A, Mulley G. History of the development of geriatric medicine in the UK Postgrad Med J 2003 ; 79 (930) : 229-234.
PubMed
2) Cigolle CT, et al. Geriatric conditions and disability : the Health and Retirement Study. Ann Intern Med 2007 ; 147 (3) : 156-164.
PubMed
3) 日本老年医学会. フレイルに関する日本老年医学会からのステートメント. http://www.jpn-geriat-soc.or.jp/info/topics/pdf/20140513_01_01.pdf
 
4) Fried LP, et al. Frailty in older adults : evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001 ; 56 (3) : M146-156.
PubMed
5) 山田陽介ほか. <特集 超高齢社会への提言-鍵は介護予防にあり> フレイルティ & サルコペニアと介護予防. 京府医大誌 2012 ; 121 (10) : 535-547. http://www.f.kpu-m.acjp/k/jkpum/pdf/121/121-10/yamada12110.pdf
 
6) Yuki A, et al. Epidemiology of frailty in elderly Japanese. J Phys Fitness Sports Med 2016 ; 5 (4) : 301-307.
 
7) Rolfson DB, et al. Validity and reliability of the Edmonton Frail Scale. Age Ageing 2006 ; 35 (5) : 526-529.
PubMed
8) Warren MW. Care of the chronic aged sick. Lancet 1946 : 1 (6406) : 841-843.
PubMed
9) Warren MW. Care of the chronic sick : a case for treating chronic sick in blocks in a general hospital. Br Med J 1943 ; 2 (4329) : 822-823.
 
10) Stuck AE, et al. Comprehensive geriatric assessment : a meta-analysis of controlled trials. Lancet 1993 ; 342 (8878) : 1032-1036,
PubMed
11) Kuo HK, et al. The influence of outpatient comprehensive geriatric assessment on survival : a meta-analysis. Arch Gerontol Geriatr 2004 ; 39 (3) : 245-254.
PubMed
12) Ellis G, et al. Comprehensive geriatric assessment for older adults admitted to hospital : meta-analysis of randomised controlled trials. BMJ 2011 ; 343 : d6553.
PubMed
13) Deschodt M, et al. Impact of geriatric consultation teams on clinical outcome in acute hospitals : a systematic review and meta-analysis. BMC Med 2013 ; 11 : 48.
PubMed
14) Ellis G, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev 2017 ; 9 : CD006211.
 
15) Eamer G, et al. Comprehensive geriatric assessment for older people admitted to a surgical service. Cochrane Database Syst Rev 2018 ; 1 : CD012485.
PubMed
16) Final Update Summary : Falls Prevention in Community-Dwelling Older Adults : Interventions. U. S. Preventive Services Task Force. March 2018. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/falls-preventionin-older-adults-interventionsl
 
17) 村永信吾, 平野清孝. 2ステップテストを用いた簡便な歩行能力推定法の開発. 昭和医学会雑誌 2003 ; 63 (3) : 301-308.
 
18) Yamaguchi H, et al. Yamaguchi Fox-Pigeon Imitation Test : a rapid test for dementia. Dement Geriatr Cogn Disord 2010 ; 29 (3) : 254-258.
 
19) Final Update Summary : Cognitive Impairment in Older Adults : Screening. U. S. Preventive Services Task Force. September 2016 https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/cognitiveimpairment-in-older-adults-screening?ds=1&s=cognitive
 
20) 鳥羽研二ほか. 高齢者総合的機能評価簡易版CGA7の開発. 日本老年医学会雑誌 2004 ; 41 : 124.
 
21) 岩本俊彦ほか. 高齢者医療の現場における高齢者総合的機能評価 (CGA) 簡易版「Dr. SUPERMAN」の有用性の検討. Geriatic Medicine (老年医学) 2012 ; 50 (9) : 1070-1075.
 
22) Rozzini R, et al. Delirium induced by neuropsychological tests. J Am Geriatr Soc 1989 ; 37 (7) : 666.
PubMed
和田忠志 (編). <スーパー総合医> 高齢者外来診療. 中山書店 ; 2014.
 
川越正平 (編著). 在宅医療バイブル-家庭医療学, 老年医学, 緩和医療学の3領域からアプローチする. 日本医事新報社 ; 2014.
 
Rubenstein LZ. An overview of comprehensive geriatric assessment : rationale, history, program models, basic components. In : Rubenstein LZ, et al eds. Geriatric Assessment Technology : The State of the Art. Springer ; 1995. pp1-10.
 
Osterweil D, et al (eds). Comprehensive Geriatric Assessment. McGraw Hill ; 2000.
 
Bernabei R, et al. The comprehensive geriatric assessment : when, where, how. Crit Rev Oncol Hematol 2000 ; 33 (1) : 45-56.
PubMed
Wieland D, et al. Comprehensive Geriatric Assessment. Cancer Control 2003 ; 10 (6) : 454-462.
PubMed
P.156 掲載の参考文献
1) Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 2004 ; 16 (2) : 129-140.
PubMed
2) Roberts R, Knopman DS. Classification and epidemiology of MCI. Clin Geriatr Med 2013 ; 29 (4) : 753-772.
PubMed
3) Beydoun MA, et al. Epidemiologic studies of modifiable factors associated with cognition and dementia : systematic review and meta-analysis. BMC Public Health 2014 ; 14 : 643-676.
PubMed
4) Pandharipande PP, et al. Long-term cognitive impairment after critical illness. N Engl J Med 2013 ; 369 (14) : 1306-1316.
PubMed
5) Livingston G, et al. Dementia prevention, intervention, and care. Lancet 2017 ; 390 (10113) : 2673-2734.
PubMed
6) Kelly ME, et al. The impact of exercise on the cognitive functioning of healthy older adults : a systematic review and meta-analysis. Ageing Res Rev 2014 ; 16 : 12-31.
PubMed
7) Elwood P, et al. Healthy lifestyles reduce the incidence of chronic diseases and dementia : evidence from the Caerphilly cohort study. PLoS One 2013 ; 8 (12) : e81877.
PubMed
8) Xu G, et al. Alcohol consumption and transition of mild cognitive impairment to dementia. Psychiatry Clin Neurosci 2009 ; 63 (1) : 43-49.
PubMed
日本神経学会 (監修) /「認知症疾患診療ガイドライン」作成委員会 (編). 認知症疾患診療ガイドライン 2017. 医学書院 ; 2017.
 
Ngandu T, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER) : a randomised controlled trial. Lancet 2015 ; 385 (9984) : 2255-2263.
 
P.160 掲載の参考文献
1) Wakabayashi H, Sashika H, Malnutrition is associated with poor rehabilitation outcome in elderly inpatients with hospital-associated deconditioning : aprospective cohort study. J Rehabil Med 2014 ; 46 : 277- 282.
 
2) Fried LP, et al. Frailty in older adults : evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001 ; 56 : M146-156.
PubMed
3) Morley JE, et al. Frailty consensus : a call to action. J Am Med Dir Assoc 2013 ; 14 : 392-397.
 
4) Kelaiditi E, et al. Cognitive frailty : rational and definition from an (I. A. N. A./I. A. G. G.) international consensus group. J Nutr Health Aging 2013 ; 17 : 726-734.
 
5) Makizako H. et al. Social Frailty in Community-Dwelling Older Adults as a Risk Factor for Disability. J Am Med Dir Assoc 2015 ; 16 : 1003. e7-11.
 
6) Chen LK, et al. Sarcopenia in Asia : consensus report of the asian working group for sarcopenia, J Am Med Dir Assoc 2014 : 15 : 95-101.
 
7) Maeda K, et al. Predictive Accuracy of Calf Circumference Measurements to Detect Decreased Skeletal Muscle Mass and European Society for Clinical Nutrition and Metabolism-Defined Malnutrition in Hospitalized Older Patients. Ann Nutr Metab 2017 ; 71 (1-2) : 10-15.
PubMed
8) Wakabayashi H. Rehabilitation nutrition in general and family medicine. J Gen Fam Med 2017 ; 18 (4) : 153-154.
PubMed
9) Maeda K, et al. Decreased Skeletal Muscle Mass and Risk Factors of Sarcopenic Dysphagia : A Prospective Observational Cohort Study. J Gerontol A Biol Sci Med Sci 2017 ; 72 (9) : 1290-1294.
PubMed
P.164 掲載の参考文献
1) National Institute for Health and Care Excellence : Pressure Ulcers : prevention and management. clinical guideline (CG179). 2014. https://www.nice. org.uk/guidance/cg179
 
2) Bluestein D, Javaheri A. Pressure ulcers : prevention, evaluation, and management. Am Fam Physician 2008 ; 78 (10) : 1186-1196.
PubMed
3) Raetz JG, Wick KH. Common questions about pressure ulcers. Am Fam Physician 2015 ; 92 (10) : 888-894.
PubMed
4) NPUAP/EPUAP/PPPIA. Prevention and Treatment of Pressure Ulcer. Clinical Practice Guideline. Cambridge Media : 2014.
 
5) 日本褥瘡学会 (編). 褥瘡予防・管理ガイドライン. 照林社 ; 2009. pp39-68. (第4版 <2015> は以下より閲覧可能 http://minds.jcqhc.or.jp/n/med/4/med0254/G0000915/0001)
 
6) Perry D, et al. Pressure ulcer prevention and treatment protocol. 3rd ed. Institute for Clinical Systems Improvement (ICSI) ; 2012. http://lnx.mednemo.it/wp-content/uploads/2010/11/febb7157.pdf
 
P.168 掲載の参考文献
1) 骨粗鬆症の予防と治療ガイドライン作成委員会 (編). 骨粗鬆症の予防と治療ガイドライン 2015年版. 日本骨粗鬆症学会/日本骨代謝学会/骨粗鬆症財団 ; 2015. http://www.josteo.com/ja/guideline/doc/15_1.pdf
 
2) FRAX(R) 骨折リスク評価ツール https://www.sheffield.ac.uk/FRAX/tool.jsp?lang=jp (最終アクセス 2018/4/30)
 
3) Tamaki J, et al. Fracture risk prediction using FRAX(R) : a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 2011 ; 22 : 3037-3045.
 
4) Vieira ER, et al. Prevention of falls in older people living in the community. BMJ 2016 ; 353 : i1419.
PubMed
5) Moncada LVV, Mire LG. Preventing falls in older persons. Am Fam Physician 2017 ; 96 : 240-247.
PubMed
6) US Preventive Services Task Force, et al. Interventions to Prevent Falls in Community-Dwelling Older Adults : US Preventive Services Task Force Recommendation Statement. JAMA 2018 ; 319 (16) : 1696-1704.
PubMed
7) Shumway-Cook A, et al. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go test. Phys Ther 2000 ; 80 : 896-903.
PubMed
8) 岡村太郎ほか. 生活環境改善による高齢者の転倒予防 在宅訪問指導実施マニュアル. 2007. http://www.clg.niigata-u.ac.jp/~pub/pubnet/reports/H18tagami/H18tagami.pdf (最終アクセス 2018/4/30)
 
P.171 掲載の参考文献
1) Bergen G, et al. Falls and Fall Injuries Among Adults Aged ≧ 65 Years-United States, 2014. MMWR Morb Mortal Wkly Rep 2016 ; 65 (37) : 993-998.
 
2) Schiller JS, et al. Fall injury episodes among noninstitutionalized older adults : United States, 2001-2003. Adv Data 2007 ; (392) : 1-16.
PubMed
3) Stevens JA, et al. The costs of fatal and non-fatal falls among older adults. Inj Prev 2006 ; 12 : 290-295.
PubMed
4) Deandrea S, et al. Risk factors for falls in community-dwelling older people : a systematic review and meta-analysis. Epidemiology 2010 ; 21 (5) : 658-668.
PubMed
5) Luo H, et al. Physical restraint use and falls in nursing homes : a comparison between residents with and without dementia. Am J Alzheimers Dis Other Demen 2011 ; 26 (1) : 44-50.
PubMed
6) Tinetti ME, et al. Risk factors for falls among elderly persons living in the community. N Engl J Med 1988 ; 319 : 1701-1707.
PubMed
7) 2010 AGS/BGS Clinical Practice Guideline : Prevention of Falls in Older Persons. http://www.medcats.com/FALLS/frameset.htm
 
8) Inouye SK, et al. Clarifying confusion : the confusion assessment method. A new method for detection of delirium. Ann Intern Med 1990 ; 113 : 941-948.
 
9) Inouye SK, et al. Delirium in elderly people. Lancet 2014 ; 383 (9920) : 911-922.
PubMed
10) Fong T, et al. The interface between delirium and dementia in elderly adults. Lancet Neurol 2015 ; 14 : 823-832.
PubMed
11) Inouye SK, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999 ; 340 : 669-676.
PubMed
12) Rubin F et al. Sustainability and scalability of the hospital elder life program at a community hospital. J Am Geriatr Soc 2011 ; 59 (2) : 359-365.
 
P.173 掲載の参考文献
1) 介護予防マニュアル改訂委員会 (編). 介護予防マニュアル改訂版. 三菱総合研究所 ; 2012. http://www.mhlw.go.jp/topics/2009/05/dl/tp0501-_1.pdf
 
2) Chodzko-Zaijko WJ, et al, American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009 ; 41 : 1510-1530.
 
3) Mackenzie CS, et al. Evaluation of a psychiatric day hospital program for elderly patients with mood disorders. Int Psychogeriatr 2006 ; 18 : 631-641.
PubMed
4) 大塚理加ほか. 介護保険法改正によるサービス利用制限の影響と残された課題-東京都の地域包括支援センターへの調査から. 厚生の指標 2008 ; 55 (7) : 1-8.
 
P.180 掲載の参考文献
1) Temel JS, et al. Early palliative care for patients with metastatic non-small-cell lung carlcer, N Engl J Med 2010 ; 363 : 733-742.
PubMed
2) Haun MW, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev 2017 ; 6 : CD011129.
PubMed
3) Yoong J, et al. Early palliative care in advanced lung cancer : a qualitative study. JAMA Intern Med 2013 ; 173 : 283-290.
PubMed
4) The AM, et al. Collusion in doctor-patient communication about imminent death : an ethnographic study. BMJ 2000 ; 321 (7273) : 1376-1381.
PubMed
5) Temel JS, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer : results of a randomized study of early palliative care. J Clin Oncol 2011 ; 29 : 2319-2326.
PubMed
6) Mack JW, et al. Associations between end-of-life discussion characteristics and care received near death : a prospective cohort study. J Clin Oncol 2012 ; 30 : 4387-4395.
 
7) Yamaguchi T, et al. Effects of End-of-Life Discussions on the Mental Health of Bereaved Family Members and Quality of Patient Death and Care. J Pain Symptom Manage 2017 ; 54 : 17-26. e1.
 
P.183 掲載の参考文献
大野裕, 田中克俊. 簡易型認知行動療法実践マニュアル. きずな出版 ; 2017.
 
井原裕. 生活習慣病としてのうつ病. 弘文堂 ; 2013.
 
P.187 掲載の参考文献
1) 日本精神神経学会 (日本語版用語監修). DSM-5 精神疾患の診断・統計マニュアル. 医学書院 ; 2014. pp356-362.
 
2) 日本睡眠学会. 睡眠薬の適正な使用と休薬のための診断ガイドライン. 2014年7月22日更新. http://jssr.jp/data/pdf/suiminyaku-guideline.pdf
 
3) Spielman A, et al. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987 ; 10 : 541-553.
PubMed
4) 厚生労働省健康局. 健康づくりのための睡眠指針 2014. http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/0000047221.pdf
 
P.190 掲載の参考文献
1) Patterson WM, et al. Evaluation of suicidal patients : the SAD PERSONS scale. Psychosomatics. 1983 ; 24 (4) : 343-5, 348-9.
 
2) Hockberger RS, Rothstein RJ. Assessment of suicide potential by non-psychiatrists using the SAD PERSONS score. J Emerg Med 1988 ; 6 (2) : 99-107.
 
3) Dube P, et al. The p4 screener : evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients. Prim Care Companion J Clin Psychiatry 2010 ; 12 (6). pii : PCC.10m00978,
 
4) Schneider RKほか (著) /井出広幸ほか (監訳). ACP内科医のための「こころの診かた」-ここから始める! あなたの心療. 丸善 ; 2009.
 
5) 松本俊彦. もしも「死にたい」と言われたら-自殺リスクの評価と対応. 中外医学社 ; 2015.
 
今村弥生ほか (編). 生きると向き合う-わたしたちの自殺対策. 南山堂 ; 2017.
 
P.193 掲載の参考文献
1) Prather AA, et al. Behaviorally assessed sleep and susceptibility to the common cold. Sleep 2015 ; 38 (9) : 1353-1359.
 
2) Sonnentag S, Bayer UV. Switching off mentally : predictors and consequences of psychological detachment from work during off-job time. J Occup Health Psychol 2005, 10 (4) : 393-414.
PubMed
3) Kecklund G, Akerstedt T. Apprehension of the subsequent working day is associated with a low amount of slow wave sleep. Biol Psychol 2004 ; 66 (2) : 169-176.
 
P.196 掲載の参考文献
1) 警察庁交通局. 平成27年における交通事故の発生状況 (平成28年3月). 2016. https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&stat_infid=000031400112&lid=000001150496
 
2) 内閣府. 平成28年版 交通安全白書 (平成28年6月). 2016. http://www8.cao.go.jp/koutu/taisaku/h28kou_haku/index_zenbun_pdf.html
 
P.202 掲載の参考文献
1) Feely MA, et al. Preoperative testing before noncardiac surgery : guidelines and recommendations. Am Fam Physician 2013 ; 87 (6) : 414-418.
PubMed
2) Fischer SP. Cost-effective preoperative evaluation and testing. Chest 1999 ; 115 (5 Suppl) : 96S-100S.
 
3) Schein OD, et al, The value of routine preoperative medical testing before cataract surgery. Study of Medical Testing for Cataract Surgery. N Engl J Med 2000 ; 342 (3) : 168-175.
PubMed
4) Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014 ; 64 (22) : e77-137.
 
5) Kristensen SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery : cardiovascular assessment and marlagement : The Joint Task Force on non-cardiac surgery : cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014 ; 35 (35) : 2383-2431.
 
6) Rechenrnacher SJ, Fang JC. Bridging Anticoagulation : Primum Non Nocere. J Am Coll Cardiol 2015 ; 66 (12) : 1392-1403.
 
7) Douketis JD, et al. Perioperative management of antithrombotic therapy : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 ; 141 (2 Suppl) : e326S-e350S.
 
8) 平岡栄治. 心臓血管外科周術期におけるアドバンス・ケア・プランニング-望まない術後経過に適切に対応するために. Intensivist 2016 ; 8 (1) : 211-218.
 
9) Levine GN, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease. Circulation 2016 ; 134 (10) : e123-155.
PubMed
10) Qaseem A, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery : a guideline from the American College of Physicians. Ann Intern Med 2006 ; 144 (8) : 575-580.
PubMed
11) Mills E, et al. Smoking cessation reduces postoperative complications : a systematic review and meta-analysis. Am J Med 2011 ; 124 (2) : 144-154.
PubMed
12) 日本麻酔科学会. 周術期禁煙ガイドライン. 2015年 http://www.anesth.or.jp/guide/pdf/20150409-1guidelin.pdf
 
13) Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 2007 ; 4 (5) : 266-276.
PubMed
14) Simunovic N, et al. Effect of early surgery after hip fracture on mortality and complications : systematic review and meta-analysis. CMAJ 2010 ; 182 (15) : 1609-1616.
PubMed
15) 野木真将. 中断してもいい薬, 中断してはいけない薬-周術期の薬剤管理で考えるべきこと. Hospitalist 2016 ; 4 (2) : 392-399.
 
16) Narouze S, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications : guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med 2015 ; 40 (3) : 182-212.
 
P.209 掲載の参考文献
1) U. S. Public Health Service. Updated U. S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001 ; 50 (RR-11) : 1-52.
PubMed
2) Schillie S, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013 ; 62 (RR-10) : 1-19.
 
3) Kuhar DT, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013 ; 34 (9) : 875-892.
PubMed
4) Fiore AE, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza---recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011 ; 60 (1) : 1-24.
PubMed
5) Cohn AC, et al. Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013 ; 62 (RR-2) : 1-28.
PubMed
6) Briere EC, et al. Prevention and control of haemophilus influenzae type b disease : recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2014 ; 63 (RR-01) : 1-14.
 
7) Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients : recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002 ; 35 : 950-959.
 
8) Marin M, et al. Prevention of varicella : recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 ; 56 (RR-4) : 1-40.
PubMed
9) Tiwari T, et al. Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis : 2005 CDC Guidelines. MMWR Recomm Rep 2005 ; 54 (RR-14) : 1-16.
 
P.211 掲載の参考文献
1) The Review on Antimicrobial Resistance. Tackling drug-resistant infections globally : final report and recommendations. https://amr-review.org/Publications.html
 
2) 厚生労働省. 薬剤耐性 (AMR) 対策について. http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000120172.html
 
3) Barlam TF, et al. Executive Summary : Implementing an Antibiotic Stewardship Program : Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016 ; 62 (10) : 1197-1202.
 
4) de la Poza Abad M, et al, Prescription strategies in acute uncomplicated respiratory infections : a randomized clinical trial. JAMA Intern Med 2016 ; 176 (1) : 21-29.
PubMed
厚生労働省健康局結核感染症課. 抗微生物薬適正使用の手引き 第一版. http://amrcrc.ncgm.go.jp/050/index.html
 
P.214 掲載の参考文献
小泉俊三. 医学と医療の最前線 Choosing Wiselyキャンペーンについて. 日本内科学会雑誌 2016 ; 105 (12) : 2441-2449.
 
小泉俊三. Choosing Wiselyキャンペーンは何をめざしているか-序に代えて. 医学のあゆみ 2018 ; 265 (2) : 177.
Medical*Online

3章 救急受診・重症化予防 - ACSCの考え方

P.219 掲載の参考文献
1) Bardsley M, et al. Is secondary preventive care improving? Observational study of 10-year trends in emergency admissions for conditions amenable to ambulatory care. BMJ Open 2013 ; 3 (1) : e002007
PubMed
2) Sundmacher L, et al. Which hospitalisations are ambulatory care-sensitive, to what degree, and how could the rates be reduced? Results of a group consensus study in Germany. Health Policy 2015 ; 119 : 1415-1423.
PubMed
3) Sasabuchi Y, et al. Increase in avoidable hospital admissions after the Great East Japan Earthquake. J Epidemiol Community Health 2017 ; 71 : 248-252.
PubMed
P.222 掲載の参考文献
1) Saultz JW. Textbook of Family Medicine : Defining and Examining the Discipline. McGraw-Hill ; 2000.
 
2) Bazemore A, et al. More comprehensive care among family physicians is associated with lower costs and fewer hospitalizations. Ann Fam Med 2015 ; 13 (3) : 206-213.
PubMed
3) Lin W, et al. Continuity of diabetes care is associated with avoidable hospitalizations : evidence from Taiwan's National Health Insurance scheme. Int J Qual Health Care 2010 ; 22 (1) : 3-8.
PubMed
4) Gill JM, Manious AG III. The role of provider continuity in preventing hospitalizations. Arch Fam Med 1998 ; 7 : 352-357.
 
5) Barker I, et al. Association between continuity of care in general practice and hospital admissions for ambulatory care sensitive conditions : cross sectional study of routinely collected, person level data. BMJ 2017 ; 356 : j84.
PubMed
6) 岡田唯男. Starfieldの4+3 (1992, 1998) その3. 実践誌プライマリ・ケア 2017 ; 2 (4) : 56.
 
7) Chang CH. et al. Primary care physician workforce and Medicare beneficiaries' health outcomes. JAMA 2011 ; 305 (20) : 2096-2104.
PubMed
8) Lippi Bruni M, et al. Economic incentives in general practice : the impact of pay-for-participation and pay-for-compliance programs on diabetes care. Health Policy 2009 ; 90 (2-3) : 140-148.
 
9) Rizza P, et al. Preventable hospitalization and access to primary health care in an area of Southern Italy. BMC Health Serv Res 2007 ; 7 (1) : 134.
 
10) Lavoie JG, et al. Have investments in on-reserve health services and initiatives promoting community control improved First Nations' health in Manitoba? Soc Sci Med 2010 ; 71 : 717-724.
 
11) Mainous AG III, et al. Impact of insurance and hospital ownership on hospital length of stay among patients with ambulatory care-sensitive conditions. Ann Fam Med 2011 ; 9 (6) : 489-495.
 
12) Birtwhistle RV, et al. Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners. BMJ 2004 ; 328 (7433) : 204.
PubMed
13) Schectman G, et al. Prolonging the return visit interval in primary care. Am J Med 2005 ; 118 : 393-399.
PubMed
14) Ng E, et al. Hospitalization risk in a type 2 diabetes cohort. Health Rep 2010 ; 21 (3) : 29-35.
 
15) Wermeling PR, et al. Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients : a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study). Diabetes Obes Metab 2014 ; 16 (9) : 841-849.
PubMed
P.227 掲載の参考文献
1) 総務省消防庁 [HP]. 平成28年版 救急救助の現況, 2017. http://www.fdma.go.jp/neuter/topics/fieldList9_3_2016.html (平成29年版は http://www.fdma.go.jp/neuter/topics/fieldList9_3.htmlで閲覧できる)
 
2) Wilkinson R, Marmot M (eds). Social Determinants of Health : the Solid Facts. WHO ; 2003. http://apps.who.int/iris/handle/10665/108082
 
3) Pickett KE, Wilkinson RG. Income inequality and health : a causal review. Soc Sci Med 2015 ; 128 : 316-326.
 
4) 佐々木由理ほか. 高齢者うつの地域診断指標としての社会的サポートの可能性-2013年日本老年学的評価研究 (JAGES) より. 老年精神医学雑誌 2015 ; 26 (9) : 1019-1027.
Medical*Online
5) 斉藤雅茂ほか. 健康指標との関連からみた高齢者の社会的孤立基準の検討-10年間のAGESコホートより. 日本公衆衛生雑誌 2015 ; 62 (3) : 95-105.
 
6) Hikichi H, et al. Effect of a community intervention programme promoting social interactions on functional disability prevention for older adults : propensity score matching and instrumental variable analyses. JAGES Taketoyo study. J Epidemiol Community Health 2015 ; 69 (9) : 905-910.
PubMed
P.230 掲載の参考文献
1) WHO. Oral Rehydration Salts : Production of the New ORS. 2006. http://apps.who.int/iris/bitstream/10665/69227/1/WHO_FCH_CAH_06.1.pdf?ua=1&ua=1 (最終アクセス 2017/10/04)
 
2) 加藤英治. <総合診療ブックス> 症状でみる子どものプライマリ・ケア. 医学書院 ; 2010. pp166-193.
 
3) Practice parameter : the management of acute gastroenteritis in young children. American Academy of Pediatrics, Provisional Committee on Quality Improvement, Subcommittee on Acute Gastroenteritis. Pediatrics 1996 ; 97 ; 424-435. http://pediatrics.aappublications.org/content/pediatrics/97/3/424.full.pdf
 
4) IDATENセミナーテキスト編集委員会 (編). 市中感染症診療の考え方と進め方. 医学書院 ; 2009. pp83-84.
 
藤沼康樹 [HP]. 高齢者のAmbulatory care-sensitive conditionsと家庭医. http://fujinumayasuki.hatenablog.com/entry/2013/10/08/162442 (最終アクセス 2017/10/04)
 
P.233 掲載の参考文献
1) Somers MJ. Clinical assessment and diagnosis of hypovolemia (dehydration) in children. In : UpToDate, Post TW (ed), UpToDate, Waltham MA. (accessed on August 06, 2017) https://www.uptodate.com/contents/clinical-assessment-and-diagnosis-of-hypovolemia-dehydration-in-children
 
2) 遠藤文夫 (編). 最新ガイドライン準拠 小児科診断・治療指針, 改訂第2版. 中山書店 ; 2017. pp. 1192-1198.
 
3) Freedman S. Oral rehydration therapy, In : UpToDate, Post TW (ed), UpToDate, Waltham MA. (accessed on August 06, 2017) https://www.uptodate.com/contents/oral-rehydration-therapy
 
P.236 掲載の参考文献
1) 谷口英喜ほか. 高齢者用かくれ脱水発見シートの開発-介護老人福祉施設の通所者を対象とした検討. 日本老年医学会雑誌 2015 ; 52 : 359-366.
 
2) 秋山正子. 高齢者における脱水症の病態と対策. 臨床栄養 2014 ; 125 : 275-280.
Medical*Online
3) Vellas B, et al. Overview of the MNA(R) : its history and challenges. J Nutr Health Aging 2006 ; 10 : 456-465.
 
4) Rubenstein LZ, et al. Screening for undernutrition in geriatric practice : developing the short-form mini nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 2001 ; 56 (6) : M366-372.
 
5) Guigoz Y. The Mini-Nutritional Assessment (MNA(R)) review of the literature : what does it tell us? J Nutr Health Aging 2006 ; 10 : 466-487.
PubMed
6) MNA(R) Short Form [簡易栄養状態評価表] 日本語版 http://www.mna-elderly.com/forms/mini/mna_mini_japanese.pdf
 
7) Evans WJ, et al. Cachexia : a new definition. Clin Nutr 2008 ; 27 : 793-799.
PubMed
P.241 掲載の参考文献
1) 伊東優ほか. 名古屋掖済会病院歯科口腔外科における入院患者の臨床統計的検討-最近8年間の実態と傾向について. 愛知学院大学歯学会誌 2016 ; 54 (1) : 13-19.
Medical*Online
2) 市原左知子ほか. さくら病院歯科口腔外科での過去3年間における入院患者の臨床統計学的観察. 愛知学院大学歯学会誌 2008 ; 46 (4) : 515-520.
 
3) 加藤雅民ほか. 公立陶生病院歯科口腔外科における過去8年間の入院患者の臨床統計的観察. 愛知学院大学歯学会誌 1997 ; 35 (3) : 439-447.
Medical*Online
4) Walsh T, et al. Fluoride toothpastes of different concentrations for preventing dental caries in children and adolescents. Cochrane Database Syst Rev 2010 ; (1) : CD007868.
 
安井利一ほか (編). 口腔保健・予防歯科学. 医歯薬出版 ; 2017.
 
日本歯科保存学会 (編). う蝕治療ガイドライン, 第2版. 永末書店 ; 2015. http://www.hozon.or.jp/member/publication/guideline/file/guideline_2015.pdf
 
日本歯周病学会 (編), 歯周治療の指針 2015. 医歯薬出版 ; 2016. http://www.perio.jp/publication/upload_file/guideline_perio_plan2015.pdf
 
顎骨壊死検討委員会. 骨吸収抑制薬関連顎骨壊死の病態と管理-顎骨壊死検討委員会ポジションペーパー 2016 日本骨代謝学会 [HP] http://jsbmr.umin.jp/guide/pdf/bppositionpaper2016.pdfなどで閲覧可能.
 
P.244 掲載の参考文献
1) Linder TE, et al. Prevention of acute mastoiditis : fact or fiction? Int J Pediatr Otorhinolaryngol 2000 ; 56 (2) : 129-134.
PubMed
2) Gisselsson-Solen M. Acute otitis media in children-current treatment and prevention. Curr Infect Dis Rep 2015 ; 17 (5) : 476.
PubMed
3) Gulani A, Sachdev HS. Zinc supplements for preventing otitis media. Cochrane Database Syst Rev 2014 ; (6) : CD006639.
PubMed
4) Leach AJ, Morris PS. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev 2006 ; (4) : CD004401.
PubMed
5) Duse M, et al. Rhinosinusitis : prevention strategies. Pediatr Allergy Immunol 2007 ; 18 (Suppl 18) : 71-74,
 
6) Biagini JM, et al. Environmental risk factors of rhinitis in early infancy. Pediatr Allergy Immunol 2006 ; 17 (4) : 278-284.
PubMed
7) Uhari M, et al. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis 1996 ; 22 (6) : 1079-1083.
PubMed
8) Ilicali OC, et al. Relationship of passive cigarette smoking to otitis media. Arch Otolaryrlgol Head Neck Surg 1999 ; 125 (7) : 758-762.
PubMed
9) Marchisio P, et al. Medical prevention of recurrent acute otitis media : an updated overview. Expert Rev Anti Infect Ther 2014 ; 12 (5) : 611-620.
PubMed
10) Kaur R, et al. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. Pediatrics 2017 ; 140 (3). pii : e20170181.
 
Bennett JE, et al. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th ed, Elsevier Churchill Livingstone ; 2014.
 
Flint PW, et al. Cummings Otolaryngology : Head and Neck Surgery, 6th ed, Elsevier Churchill Livingstone ; 2015.
 
P.247 掲載の参考文献
日本消化器病学会 (編). 消化性潰瘍診療ガイドライン 2015 (改訂第2版). 南江堂 ; 2015.
 
小林健二. 消化器疾患の診かた, 考えかた. 中外医学社 : 2017.
 
P.250 掲載の参考文献
1) 住永佳久ほか (監訳), ワシントン外科マニュアル 第3版. メディカル・サイエンス・インターナショナル, 2009.
 
2) 寺下新太郎ほか. 診断の遅滞した小児虫垂炎性腹膜炎の臨床像解析. 小児科臨床 2016 ; 69 : 827-832.
Medical*Online
3) 竹内慎哉. 急性虫垂炎の診断. 日本外科感染症学会雑誌 2015 ; 12 : 23-29.
Medical*Online
4) Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med 1986 ; 15 : 557-564.
 
5) Samuel M. Pediatric appendicitis score. J Pediatr Surg 2002 ; 37 : 877-881.
 
6) Ohle R, et al. The Alvarado score for predicting acute appendicitis : a systematic review. BMC Med 2011 ; 9 : 139.
PubMed
7) Brenner DJ, Hall EJ. Computed tomography : an increasing source of radiation exposure. N Engl J Med 2007 ; 357 : 2277-2284.
PubMed
8) 渡邊昌彦ほか. 内視鏡外科手術に関するアンケート調査-第13回集計結果報告. 日本内視鏡外科学会雑誌 2016 ; 21 : 655-810.
 
9) 安達洋祐. 外科医のためのエビデンス. 医学書院 ; 2015. pp2-6.
 
10) Gilbert DNほか (編) /菊池賢ほか (監修). 日本語版サンフォード感染症治療ガイド 2017 (第47版). ライフサイエンス出版 ; 2017.
 
P.253 掲載の参考文献
1) CDC [HP]. Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009. https://www.cdc.gov/infectioncontrol/pdf/guidelines/cauti-guidelines.pdf
 
2) Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001 ; 17 : 299-303.
PubMed
3) Saint S, et al, A program to prevent catheter-associated urinary tract infection in acute care. N Engl J Med 2016 ; 374 : 2111-2119.
 
4) Jepson RG, et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012 ; 10 : CD001321.
PubMed
5) Schwenger EM, et al. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev. 2015 Dec 23 ; (12) : CD008772.
PubMed
P.257 掲載の参考文献
1) Raff AB, Kroshinsky D. Cellulitis : a review. JAMA 2016 ; 316 (3) : 325-337.
PubMed
2) Enzler MJ, et al. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2011 ; 86 (7) : 686-701.
PubMed
3) Stevens DL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections : 2014 update by the infectious diseases society of America. Clin Infect Dis 2014 ; 59 (2) : 147-159.
 
4) Bruun T, et al. Early response in cellulitis : a prospective study of dynamics and predictors. Clin Infect Dis 2016 ; 63 (8) : 1034-1041.
PubMed
5) Weng QY, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol 2016 ; doi : 10.1001/jamadermatol.2016.3816
 
P.260 掲載の参考文献
1) Headley AJ. Necrotizing soft tissue infections : a primary care review. Am Fam Physician 2003 ; 68 (2) : 323-328.
PubMed
2) Anaya DA, Dellinger EP. Necrotizing soft-tissue infection : diagnosis and management. Clin Infect Dis 2007 ; 44 (5) : 705-710.
PubMed
3) Chen KJ, et al. Presentation and outcomes of necrotizing soft tissue infections. Int J Gen Med 2017 ; 10 : 215-220.
PubMed
4) Farber A, Eberhardt RT. The current state of critical limb ischemia : a systematic review. JAMA Surg 2016 ; 151 (11) : 1070-1077.
PubMed
5) Harrison WD, Kapoor B. Necrotizing soft tissue infection : principles of diagnosis and management. Orthopaedics and Trauma 2016 ; 33 (3) : 223-231.
 
6) Khan NA, et al. Does the clinical examination predict lower extremity peripheral arterial disease? JAMA 2006 ; 295 (5) : 536-546.
PubMed
P.263 掲載の参考文献
日本産科婦人科学会/日本産婦人科医会 (編/監修). 産婦人科診療ガイドライン-婦人科外来編 2017. 日本産科婦人科学会 ; 2017.
 
井上真智子 (編) /柴田綾子, 水谷佳敬 (著). 女性の救急外来 ただいま診断中! 中外医学社 ; 2017.
 
CDC [HP]. Pelvic innammatory disease (PID) https://www.cdc.gov/std/tg2015/pid.htm (最終アクセス 2017/9/21)
 
USPSTF (U. S. Preventive Services Task Force) [HP]. Final Recommendation Statement Chlamydia and Gonorrhea : Screening https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/chlamydia-and-gonorrhea-screening (最終アクセス 2017/9/21)
 
Schoeman SA, et al. Assessment of best single sample for finding chlamydia in women with and without symptoms : a diagnostic test study. BMJ 2012 ; 345 : e8013.
PubMed
Stewart CM, et al. Assessment of self taken swabs versus clinician taken swab cultures for diagnosinggonorrhoea in women : single centre, diagnostic accuracy study. BMJ 2012 ; 345 : e8107.
PubMed
P.267 掲載の参考文献
1) 厚生労働省 [HP]. 平成28年国民健康・栄養調査結果の概要. http://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/kekkagaiyou_7.pdf
 
2) 厚生労働省 [HP]. 平成26年 (2014) 患者調査の概況. http://www.mhlw.go.jp/toukei/saikin/hw/kanja/14/index.html
 
3) Walker RL, et al. Hospitalization for uncomplicated hypertension : an ambulatory care sensitive condition. Can J Cardiol 2013 ; 29 (11) : 1462-1469.
PubMed
4) Walker RL, et al. Relationship between primary care physician visits and hospital/emergency use for uncomplicated hypertension, an ambulatory care-sensitive condition. Can J Cardiol 2014 ; 30 (12) : 1640-1648.
PubMed
5) Walker RL, et al. ACSC Indicator : testing reliability for hypertension. BMC Med Inform Decis Mak 2017 ; 17 : 90.
PubMed
6) Ikeda N, et al. What has made the population of Japan healthy? Lancet 2011 ; 378 (9796) : 1094-1105.
PubMed
7) 日本高血圧学会高血圧治療ガイドライン作成委員会 (編). 高血圧治療ガイドライン 2014. 日本高血圧学会 ; 2014. 電子版 http://www.jpnsh.jp/download_gl.html
 
8) Thomopoulos C, et al. Effects of blood pressure lowering on outcome incidence in hypertension : 4. Effects of various classes of antihypertensive drugs-overview and meta-analyses. J Hypertens 2015 ; 33 (2) : 195-211.
PubMed
9) Freund T, et al. Strategies for reducing potentially avoidable hospitalizations for ambulatory care-sensitive conditions. Ann Fam Med 2013 ; 11 (4) : 363-370.
PubMed
10) U. S. Preverltive Services Task Force [HP]. High Blood Pressure in Adults (Hypertension) : Screening. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/high-blood-pressure-in-adults-screening (最終アクセス 2017年10月)
 
11) Gauer R. Severe asymptomatic hypertension : evaluation and treatment. Am Fam Physician 2017 ; 95 (8) : 492-500.
PubMed
P.270 掲載の参考文献
1) 日本循環器学会. 虚血性心疾患の一次予防ガイドライン (2012年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2012_shimamoto_h.pdf
 
2) Stone NJ, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. https://doi.org/10.1161/01.cir.0000437738.63853.7a
 
3) Fihn ST, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. https://doi.org/10.1161/CIR.0000000000000095
 
P.273 掲載の参考文献
1) Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016 ; 18 (8) : 891-975.
 
P.277 掲載の参考文献
1) Dillingham TR, et al. Limb amputation and limb deficiency : epidemiology and recent trends in the United States. South Med J 2002 ; 95 : 875-883.
PubMed
2) 日本循環器学会2014年度合同研究班報告. 末梢閉塞性動脈疾患の治療ガイドライン (2015年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2015_miyata_d.pdf
 
3) Society for Vascular Surgery lower extremity guidelines writing group, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities : Management of asymptomatic disease and claudication. J Vasc Surg 2015 ; 61 (3 Suppl) : 2S-41S,
 
4) Mills JL Sr, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System : Risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg 2014 ; 59 (1) : 220-234.
 
5) 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease.
 
6) U. S. Preventive Services Task Force [HP]. Final recommendation statement : peripheral arterial disease (PAD) and CVD in adults : risk assessment with Ankle Brachial Index. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index
 
P.283 掲載の参考文献
1) 日本糖尿病学会 (編著). 糖尿病診療ガイドライン 2016. 南江堂 ; 2016.
 
2) Standards of Medical Care in Diabetes-2018 Diabetes Care January 2018 Volume 41, Supplement 1 http://care.diabetesjournals.org/content/41/Supplement_1
 
3) Erlich DR, et al. "Lending a hand" to patients with type 2 diabetes : a simple way to communicate treat-ment goals. Am Fam Physician 2014 ; 89 (4) : 256-258.
 
4) 日本老年医学会・日本糖尿病学会 (編著). 高齢者糖尿病診療ガイドライン 2017, 南江堂 ; 2017.
 
5) Holman RR, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008 ; 359 (15) : 1577-1589.
PubMed
6) Nathan DM, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005 ; 353 (25) : 2643-2653.
PubMed
7) Action to Control Cardiovascular Risk in Diabetes Study Group, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008 ; 358 (24) : 2545-2559.
 
8) Umpierrez G, Korytkowski M. Diabetic emergencies-ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016 ; 12 (4) : 222-232.
PubMed
9) Handelsman Y, et al. American association of clinical endocrinologists and American college of endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis, Endocrine Pract 2016 ; 22 (6) : 753-762.
 
10) 難波光義ほか. 糖尿病治療に関連した重症低血糖の調査委員会報告. 糖尿病 2017 ; 60 (12) : 826-842.
 
P.285 掲載の参考文献
1) 内田立身. 鉄欠乏-日本の現状と病態. 日本内科学会雑誌 2010 ; 99 (6) : 1194-1200.
 
2) Siu AL ; U. S. Preventive Services Task Force. Screening for Iron Deficiency Anemia and Iron Supplementation in Pregnant Women to Improve Maternal Health and Birth Outcomes : U. S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2015 ; 163 (7) : 529-536.
PubMed
3) 岡田定, 鉄欠乏性貧血の治療指針. 日本内科学会雑誌 2010 ; 99 (6) : 1220-1225.
 
P.289 掲載の参考文献
日本アレルギー学会喘息ガイドライン専門部会 (監修). 喘息予防・管理ガイドライン 2015. 協和企画 ; 2015.
 
Global Initiative for Asthma (GINA). 2015 Global strategy for asthma management and prevention. http://ginasthma.org/wp-content/uploads/2016/01/GINA_Report_2015_Aug11-1.pdf
 
2018 GINA Report. Global Strategy for Asthma Management and Prevention. http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/
 
田原正夫, 喘息. 横林賢一ほか (編). [Gノート別冊] Common Diseaseの診療ガイドライン-総合診療における診断・治療の要点と現場での実際の考え方. 羊土社 ; 2017. pp32-41.
 
P.293 掲載の参考文献
1) Fukuchi Y, et al. COPD in Japan : the Nippon COPD Epidemiology study. Respirology 2004 ; 9 (4) : 458-465.
PubMed
2) 日本呼吸器学会COPDガイドライン第5版作成委員会 (編). COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 2018 第5版. メディカルレビュー社 ; 2018.
 
3) 木村弘ほか. わが国における呼吸器内科医師の実態に関する調査報告. 日本呼吸器学会雑誌 2006 ; 44 : 312-318.
Medical*Online
4) 大林浩幸ほか. 慢性閉塞性肺疾患早期診断のための, プライマリケア領域におけるスパイロキャラバンの成果. 日本呼吸器学会誌 2014 ; 3 (3) : 372-379.
Medical*Online
5) Badgett RG, et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med 1993 ; 94 (2) : 188-196.
PubMed
6) Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://goldcopd.org/ (最終アクセス 2018/05/21)
 
7) 綾部悦後好ほか. 高齢者COPDの急性増悪に対するインフルエンザワクチンの効果. 日本呼吸器学会雑誌 2008 ; 46 (7) : 511-515.
 
8) Cao C, et al. Body mass index and mortality in chronic obstructive pulmonary disease : a meta-analysis. PLoS One 2012 ; 7 (8) : e43892.
PubMed
9) Yamauchi Y, et al. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulumon Dis 2016 ; 11 : 2335-2340.
 
P.297 掲載の参考文献
1) 日本神経学会 (監修). てんかん診療ガイドライン 2018. 医学書院 ; 2018,
 
2) Fisher RS, et al. ILAE official report : a practical clinical definition of epilepsy. Epilepsia 2014 ; 55 : 475-482.
PubMed
3) 飛松省三. てんかんの疫学. 2分類 (1981年, 1989年, 2010年の比較). 日本てんかん学会 (編). てんかん専門医ガイドブック-てんかんにかかわる医師のための基本知識. 診断と治療社 ; 2014. pp5-10.
 
P.301 掲載の参考文献
1) Kashiwagi S, et al. Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts : a randomized double blind placebo controlled trial. J Infect Chelnother 2013 ; 19 : 740-749.
 
2) Tsang TK, et al. Household transmission of influenza virus. Trends Microbiol 2016 ; 24 : 123-133.
PubMed
3) Lapidus N, et al. Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population. PloS One 2013 ; 8 : e60127.
PubMed
4) Bonilla Escobar BA, et al. [Legionella pneumophila pneumonia associated with the use of a home humidifier in an immunocompetent girl]. Med Clin (Barc) 2014 ; 142 : 70-72.
 
5) Satomura K, et al. Prevention of upper respiratory tract infections by gargling : a randomized trial. Am J Prev Med 2005 ; 29 : 302-307.
PubMed
6) Ernst E. The safety of massage therapy. Rheumatology (Oxford) 2003 ; 42 : 1101-1106.
PubMed
7) Apisarnthanarak A, Mundy LM. Factors associated with health care-associated 2009 influenza a (H1N1) virus infection among Thai health care workers. Clin Infect Dis 2010 ; 51 : 368-369.
PubMed
8) WHO Guidelines Approved by the Guidelines Review Committee. WHO Guidelines on Hand Hygiene in Health Care : First Global Patient Safety Challenge Clean Care Is Safer Care. World Health Organization ; 2009. http://apps.who.int/iris/bitstream/10665/44102/1/9789241597906_eng.pdf
 
9) Brun-Buisson C, et al. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011 ; 183 : 1200-1206.
PubMed
10) Hung IFN, et al. Hyperimmune IV immunoglobulin treatment : a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A (H1N1) infection. Chest 2013 ; 144 : 464-473.
PubMed
P.304 掲載の参考文献
1) Tomczyk S, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≧ 65 years : recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep 2014 ; 63 (37) : 822-825.
 
2) Grijalva CG, et al. Association between hospitalization with community acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination. JAMA 2015 ; 314 (14) : 1488-1497.
PubMed
3) Maruyama T, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents : double blind, randomized and placebo controlled trial. BMJ 2010 ; 340 : c1004.
PubMed
4) Teramoto S, et al. Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia. Respir Investig 2015 ; 53 (5) : 178-184.
PubMed
5) Caldeira D, et al. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers : systematic review and meta-analysis. BMJ 2012 ; 345 : e4260.
PubMed
6) Klompas M, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals : 2014 update. Infect Control Hosp Epidemiol 2014 ; 35 (Suppl 2) : S133-154.
 
P.306 掲載の参考文献
1) Dheda K, et al. Tuberculosis. Lancet 2016 ; 387 : 1211-1226.
PubMed
2) 日本結核病学会予防委員会・治療委員会. 潜在性結核感染症治療指針. 結核 2013 ; 88 : 497-512.
Medical*Online
P.308 掲載の参考文献
1) NICE guidance and public health outcomes 2012 https://www.nice.org.uk/advice/lgb5/chapter/Domain-2-health-improvement
 
2) WHO Global Nutrition Targets 2025 : Low Birth Weight Policy Brief http://www.who.int/nutrition/topics/globaltargets_lowbirthweight_policybrief.pdf
 
3) 厚生労働省. 平成27年国民健康・栄養調査結果の概要 http://www.mhlw.go.jp/file/04-Houdouhappyou-10904750-Kenkoukyoku-Gantaisakukenkouzoushinka/kekkagaiyou.pdf
 
4) 厚生労働省. [資料] 周産期医療体制の現状について http://www.mhlw.go.jp/file/05-Shingikai-10801000-Iseikyoku-Soumuka/0000096037.pdf
 
P.310 掲載の参考文献
1) Bethune P, et al. Which child will have a febrile seizure? Arch J Dis Child 1993 ; 147 : 35-39.
 
2) 日本小児神経学会 (監修). 小児けいれん重積治療ガイドライン 2017. 診断と治療社 ; 2017. pp24-32.
 
3) 日本小児神経学会 (監修). 熱性けいれん診療ガイドライン 2015. 診断と治療社 ; 2015. https://www.childneuro.jp/modules/about/index.php?content_id=33
 

4章 予防医療の実践

P.324 掲載の参考文献
1) Crabtree BF, et al. Delivery of clinical preventive services in family medicine offices, Ann Fam Med 2005 ; 3 (5) : 430-435.
PubMed
2) Ferrante JM, et al. Principles of the patient-centered medical home and preventive services delivery. Ann Fam Med 2010 ; 8 (2) : 108-116.
PubMed
3) Stange KC, et al. Direct Observation of Rates of Preventive Service Delivery in Community Family Practice. Prev Med 2000 ; 31 (2 Pt 1) : 167-176.
 
4) Maciosek MV, et al, Updated priorities among effective clinical preventive services. Ann Fam Med 2017 ; 15 (1) : 14-22.
 
5) Shires DA, et al. Prioritization of evidence-based preventive health services during periodic health examinations. Am J Prev Med 2012 ; 42 (2) : 164-173.
PubMed
6) 国立がん研究センター がん情報サービス [HP], がん検診受診率 (国民生活基礎調査による推計値) http://ganjoho.jp/reg_stat/statistics/stat/screening.html (最終アクセス 2017/2/1)
 
7) OECD Data [HP]. Influenza vaccination rates. https://data.oecd.org/healthcare/influenza-vaccination-rates.htm (最終アクセス 2017/2/1)
 
8) Hutchison B, et al. Provision of preventive care to unannounced standardized patients. CMAJ 1998 ; 158 (2) : 185-193.
PubMed
9) Brull R, et al. Missed opportunities for prevention in general internal medicine. CMAJ 1999 ; 160 (8) : 1137-1140.
PubMed
10) McGlynn EA, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003 ; 348 (26) : 2635-2645.
PubMed
11) Balas EA, Boren SA. Managing clinical knowledge for health care improvement. In : Bemmel J, et al editors. Yearbook of Medical Informatics 2000 : Patient-Centered Systems. Schattauer Verlagsgesellschaft mbH ; 2000 : pp65-70.
 
12) Glasziou P. The paths from research to improved health outcomes. Evid Based Med 2005 ; 10 (1) : 4-7.
 
13) Cabana MD, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999 ; 282 (15) : 1458-1465.
 
14) 前田健次. 臨床現場におけるエビデンス不適応の決定に寄与した要因の調査. 臨床現場でのエビデンス適用・不適用決定の過程と結果に関する調査研究 平成17年度 総括研究報告書 ; 2006. pp ; 187-190, 190 (1), 191-202.
 
15) Woolf SH, Johnson RE. The Break-Even Point : When Medical Advances Are Less. Ann Fam Med 2005 ; 3 (6) : 545-552,
PubMed
16) Stamos TD, et al. Effectiveness of chart prompts to improve physician compliance with the National Cholesterol Education Program guidelines. Am J Cardiol 2001 ; 88 (12) : 1420-1423, A1428.
 
17) Yarnall KS, et al. Primary care : is there enough time for prevention? Am J Public Health 2003 ; 93 (4) : 635-641.
PubMed
18) Ostbye T, et al. Is there time for marlagement of patients with chronic diseases in primary care? Ann Fam Med 2005 ; 3 (3) : 209-214.
PubMed
19) Jaen CR, et al. Competing demands of primary care : a model for the delivery of clinical preventive services. J Fam Pract 1994 ; 38 (2) : 166-171.
 
20) Covey SR (著) /ジェームス・スキナー, 川西茂 (訳). 7つの習慣-個人, 家庭, 会社, 人生のすべて 成功には原則があった!. キング・ベアー出版 ; 1996.
 
21) 大橋悦夫. LIVE HACKS! (ライブハックス!) -今を大切にして成果を5倍にする「時間畑」の法則. ゴマブックス ; 2008.
 
22) Stange KC, et al. The value of a faInily physician. J Fam Pract 1998 ; 46 (5) : 363-368.
PubMed
23) Beasley JW, et al. How many problems do family physicians manage at each encounter? A WReN study. Ann Fam Med 2004 ; 2 (5) : 405-410.
PubMed
24) Flocke SA, et al. Patient and visit characteristics associated with opportunistic preventive services delivery. J Fam Pract 1998 ; 47 (3) : 202-208.
PubMed
25) Rose G (著) /曽田研二ほか (監訳), 水嶋春朔ほか (訳). 予防医学のストラテジー-生活習慣病対策と健康増進. 医学書院 ; 1998.
 
26) Hung DY, et al. Influence of primary care practice and provider attributes on preventive service delivery. Am J Prev Med 2006. : 30 (5) : 413-422.
PubMed
27) Crawford, et al. Interactive voice response reminder effects on preventive service utilization. Am J Med Qual 2005 ; 20 (6) : 329-336.
PubMed
28) Flocke SA, et al. The association of attributes of primary care with the delivery of clinical preventive services. Med Care 1998 : 36 (8 Suppl) : AS21-30.
 
29) Pandhi N, et al. Preventive service gains from first contact access in the primary care home. J Am Board Fam Med 2011 ; 24 (4) : 351-359.
 
30) Pandhi N, et al. Number of first-contact access components required to improve preventive service receipt in primary care homes. J Gen Intern Med 2012 ; 27 (6) : 677-684.
 
31) Markovitz AR, et al. Patient-centered medical home implementation and use of preventive services : the roie of practice socioeconomic context. JAMA Intern Med 2015 ; 175 (4) : 598-606.
 
P.328 掲載の参考文献
1) Ian R McWhinney. Thomas Freeman (著) /葛西龍樹, 草場鉄周 (訳). マクウィニー家庭医療学 上巻. ぱーそん書房 ; 2013.
 
2) Kikano GE, et al. Are You Practicing 'Opportunistics' Prevention? Fam Pract Manag 2000 ; 7 : 56.
 
3) 西澤真理子, リスク コミュニケーション (エネルギーフォーラム新書 022). エネルギーフォーラム ; 2013.
 
4) Baruch Fischhoff, et al (編) /中山健夫, 杉森裕樹 (監訳), FDAリスク & ベネフィット・コミュニケーション-エビデンスに基づく健康・医療に関する指針. 丸善 ; 2015.
 
P.333 掲載の参考文献
1) Cheryl Levitt (著) /松村真司ほか (監訳). 家庭医療の質-診療所で使うツールブック. カイ書林 ; 2015.
 
2) RAND Corporation. Quality Indicators-ACOVE 3. https://www.rand.org/health/projects/acove/acove3.html
 
3) Avedis Donabedian (著) /東尚弘 (訳). 医療の質の定義と評価方法. 健康医療評価研究機構 ; 2007.
 
4) 東尚弘. 第4章 診療の質と公衆衛生の考え方. 相澤好治 (監修), 臨床医のためのパブリックヘルス. 中外医学社 ; 2010. pp78-83.
 
5) 松村真司. 標準評価項目を用いた地域診療所のプライマリケア・サービスの包括的研究評価. 科学研究費助成事業研究成果報告. 2015. https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-24616029/
 
6) Fukuma S, et al. Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data : a RAND-modified Delphi method. Clin Exp Nephrol 2017 ; 21 (2) : 247-256.
 
7) Atul Gawande (著) /吉田竜 (訳). アナタはなぜチェックリストを使わないのか? -重大な局面で "正しい決断" をする方法. 晋遊舎 ; 2011.
 
8) Resar R, et al. Using Care Bundles to Improve Health Care Quality. IHI innovation Series white paper. Institute for Healthcare Improvement ; 2012. http://www.ihi.org/resources/Pages/IHIWhitePapers/UsingCareBundles.aspx
 
9) Bradley EH, et al, A qualitative study of increasing beta-blocker use after myocardial infarction : Why do some hospitals succeed? JAMA 2001 ; 285 (20) : 2604-2611.
PubMed
Fondahn E, et al (ed). The Washington Manual of Patient Safety and Quality Improvement. Wolters Kluwer ; 2016.
 
古谷健夫 (監修), 中部品質管理協会 (編), "質創造" マネジメント-TQMの構築による持続的成長の実現. 日科技連出版社 ; 2013.
 
Quality Improvement in Primary Care https://www.ahrq.gov/research/findings/factsheets/quality/qipc/index.html
 
P.337 掲載の参考文献
1) Stone EG, et al. Interventions that increase use of adult immunization and cancer screening services : a meta-analysis. Ann Intern Med 2002 ; 136 : 641-651.
PubMed
2) Margolius D, Bodenheimer T. Transforming primary care : from past practice to the practlce of the future. Health Aff (Millwood) 2010 ; 29 : 779-784.
 
3) Jacobson Vann JC, Szilagyi P. Patient reminder and recall systems to improve immunization rates. Cochrane Database Syst Rev 2005 ; (3) : CD003941.
PubMed
4) Balas EA, et al. Improving preventive care by prompting physicians. Arch Intern Med 2000 ; 160 : 301-308.
PubMed
P.343 掲載の参考文献
1) Wilder V, et al. Community Health Needs Assessment as a Teaching Tool in a Family Medicine Resldency. Fam Med 2016 ; 48 (8) : 635-637.
 
2) 日本専門医機構. 総合診療専門研修プログラム整備基準 (2017. 7. 7). http://www.japan-senmon-i.jp/program/doc/comprehensive170707rev2.pdf (最終アクセス 2017年9月25日)
 
3) Anderson ET, McFarlane J (編) /金川克子ほか (監訳). コミュニティ アズ パートナー-地域看護学の理論と実際, 第2版. 医学書院 ; 2007.
 
4) Anderson ET, McFarlane J (eds). Community As Partner : Theory and Practice in Nursing, 7th. Lippincott Williams & Wilkins ; 2014.
 
5) Rhyne R, et al (ed). Community-Oriented Primary Care : Health Care for the 21st Century. American Public Health Association ; 1998, pp118-147.
 
6) Harper PG, et al. Implementing community-oriented primary care projects in an urban family practice residency program. Fam Med 2000 ; 32 (10) : 683-690.
 
7) 筧裕介. ソーシャルデザイン実践ガイド-地域の課題を解決する7つのステップ. 英治出版 ; 2013. pp53-91.
 
P.347 掲載の参考文献
1) Lisa F. Berkmanほか (編) /高尾総司ほか (監訳). 社会疫学 (上・下). 大修館書店 ; 2017.
 
2) Kawachi I, et al. Social capital, income inequality, and mortality. Am J Public Health 1997 ; 87 (9) : 1491-1498.
PubMed
3) Aida J, et al. Does social capital affect the incidence of functional disability in older Japanese? A prospective population-based cohort study. J Epidemiol Community Health 2013 ; 67 (1) : 42-47.
PubMed
4) Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007 ; 357 : 370-379.
 
5) Kanamori S, et al. Participation in sports organizations and the prevention of functional disability in older Japanese : the AGES Cohort Study. PLoS One 2012 ; 7 : e51061.
PubMed
P.357 掲載の参考文献
1) 厚生労働省. 平成28年 (2016) 人口動態統計 (確定数) の概況. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei16/index.html
 
2) 厚生労働省. 平成27年度 国民医療費の概況. http://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/15/dl/kekka.pdf
 
3) Ikeda N, et al. Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan : a comparative risk assessment. PLoS Med 2012 ; 9 (1) : e1001160.
PubMed
4) Sorensen K, et al. Consortium Health Literacy Project European. Health literacy and public health : a systematic review and integration of definitions and models. BMC Public Health 2012 ; 12 : 80 (日本語訳 : 中山和弘).
 
5) Nakayama K, et al. Comprehensive health literacy in Japan is lower than in Europe : a validated Japanese-language assessment of health literacy. BMC Public Health 2015 ; 15 : 505.
PubMed
6) Duong TV, et al. Measuring health literacy in Asia : Validation of the HLS-EU-Q47 survey tool in six Asian countries. J Epidemiol 2017 ; 27 (2) : 80-86.
PubMed
7) Vernon, JA, et al. Low Health Literacy : Implications for National Health Policy. Department of Health Policy, School of Public Health and Health Services, The George Washington University ; 2007. https://publichealth.gwu.edu/departments/healthpolicy/CHPR/downloads/LowHealthLiteracyReport10_4_07.pdf
 
8) [webサイト] ヘルスリテラシーとは. 健康を決める力「ヘルスリテラシーを身につける」http://www.healthliteracy.jp/
 
9) 特集 いま一度, 健康教育を考える-PDCAを回していますか? 保健師ジャーナル 2016 ; 72 (8) : 629-635.
 
10) 宮坂忠夫ほか. 健康教育の考え方. 最新保健学講座別巻 1 健康教育論. メヂカルフレンド社 ; 2011. pp2-17.
 
11) 中井俊樹. クラス規模は授業にどのような影響を与えるのか. 名古屋高等教育研究 2006 ; (6) : 5-19.
 
12) Harden RM. Death by PowerPoint-the need for a "fidget index". Med Teach 2008 ; 30 : 833-835.
PubMed
13) [webサイト] The Power of PowerPoint. http://thepopp.com/
 
14) 助友裕子ほか. 市民向け講座で得たがん予防知識が受講者以外の地域住民に普及する可能性-Learning Partner Modelを用いた検討. 日本健康教育学会誌 2016 ; 24 (1) : 12-22.
 
15) 向後千春. 上手な教え方の教科書-入門インストラクショナルデザイン. 技術評論社 ; 2015.
 
16) [webサイト] 茨城県立健康プラザ「シルバーリハビリ体操指導士養成事業」 http://www.hsc-i.jp/04_kaigo/torikumi.htm (最終アクセス 2018年1月1日)
 
17) 国立国語研究所「病院の言葉」委員会. 病院の言葉を分かりやすく-工夫の提案. 勁草書房 ; 2009.
 
18) Reynolds G (著) /熊谷小百合 (訳). プレゼンテーション ZEN, 第2版. 丸善出版 ; 2014.
 
19) 福田洋ほか (編著). ヘルスリテラシー-健康教育の新しいキーワード. 大修館書店 ; 2016.
 
20) Health literacy online : A guide to writing and designing easy-to-use health Web sites. U. S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion ; 2010. https://health.gov/healthliteracyonline/2010/Web_Guide_Health_Lit_Online.pdf
 
21) Strange KC, et al. How do family physicians prioritize delivery of multiple preventive service? J Fam Pract 1994 ; 38 : 231-237.
 
福田洋ほか (編著). ヘルスリテラシー-健康教育の新しいキーワード. 大修館書店 ; 2016.
 
佐伯胖 (監修), 渡部信一 (編). 「学び」の認知科学事典. 大修館書店 ; 2010.
 
Philip Hawkeほか (著) /福田忍 (訳). 日本人研究者のための絶対できる英語プレゼンテーション. 羊土社 ; 2011.
 
苅宿俊文ほか (編). <ワークショップと学び 2> 場づくりとしてのまなび. 東京大学出版会 ; 2012.
 
阪本直人. ヘルスリテラシーと患者さんの行動変容. Gノート 2017 ; 4 (3) : 582-595.
Medical*Online
P.362 掲載の参考文献
1) Lo B. Chapter 1 Section 1. Fundamentals of clinical ethics. Resolving Ethical Dilemmas : A Guide for Clinicians, 5th ed. Wolters Kluwer Health/Lippincott Williams & Wilkins ; 2013.
 
2) Lo B. Chapter 2 Section 1. Fundamentals of clinical ethics. Resolving Ethical Dilemmas : A Guide for Clinicians. 5th ed. Wolters Kluwer Health/Lippincott Williams & Wilkins ; 2013.
 
3) National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Department of Health, Education and Welfare. The Belmont Report. 1978. pp4-10. https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html
 
4) Sackett DL. The arrogance of preventive medicine. CMAJ 2002 ; 167 : 363-364.
PubMed
5) Krogsboll LT, et al. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012 ; 10 : CD009009.
 
6) Lo B, et al (eds). Conflict of Interest in Medical Research, Education, and Practice. 2. Principles for identifying and assessing conflicts of interest. National Academies Press ; 2009. https://www.ncbi.nlm.nih.gov/books/NBK22937/#a2001902bddd00035
 
7) Sheridan SL, et al. Shared decision making about screening and chemoprevention. a suggested approach from the U. S. Preventive Services Task Force. Am J Prev Med 2004 ; 26 : 56-66.
 
8) Lo B. Chapter 3 Section 1. Fundamentals of clinical ethics. Resolving Ethical Dilemmas : A Guide for Clinicians. 5th ed. Wolters Kluwer Health/Lippincott Williams & Wilkins ; 2013.
 
9) Dahlgren G, Whitehead M. Policies and Strategies to Promote Social Equity in Health. Institute for Futures Studies ; 1991. p11.
 
10) Slomka J, et al. Professionalism and ethics in the public health curriculum, Public Health Rep 2008 ; 123 (Suppl 2) : 27-35.
 
P.366 掲載の参考文献
1) 厚生労働省. 「療養の給付と直接関係ないサービス等の取扱いについて」の一部改正について (2016年6月24日・保医発0624第2号). http://www.mhlw.go.jp/file.jsp?id=363703&name=file/06-Seisakujouhou-12400000-Hokenkyoku/0000128581.pdf (最終アクセス 2018/01/26)
 
2) みずほ情報総研. 「複数自治体連携型大規模健幸ポイントプロジェクト実証」の実施について. https://www.mizuho-ir.co.jp/company/release/2014/swc1002.html (最終アクセス 2018/01/26)
 
3) Fineberg HV. The paradox of disease prevention : celebrated in principle, resisted in practice. JAMA 2013 ; 310 (1) : 85-90.
PubMed
4) WHO. The Case for Investing In Public Health. 2014 http://www.euro.who.int/_data/assets/pdf_file/0009/278073/Case-Investing-Public-Health.pdf (最終アクセス 2018/01/26)
 
5) Wright A, et al, Policy lessons from health taxes : a systematic review of empirical studies. BMC Public Health 2017 ; 17 (1) : 583.
PubMed

書評

最近チェックした商品履歴

Loading...